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THE INVOLVEMENT OF EPITHELIAL IN ARENAVIRUS-INDUCED 
PATHOGENESIS 
 
Nikole Leslie Margaret Warner  
April 16, 2018 
Mammalian Arenaviruses are a geographically and genetically diverse 
family of viruses, which is separated into two sub-groups; the Old World (OW) 
and New World (NW) groups.  Of the OW viruses, Lassa virus (LASV), found 
endemically in Western Africa, is an important human pathogen, causing 
hundreds of thousands of infections, and several thousand deaths annually. 
Interestingly, some villages in endemic regions, up to 45% of the population 
show seropositivity for the virus.  It is hypothesized that seropositivity is a result 
of natural infection through inhalation or ingestion of infectious particles.  
However, the exact mechanism is still unknown.   
 LASV’s natural reservoir is Mastomys natalensis, a common rat found in 
sub-Saharan Africa. Epidemiological studies have identified the inhalation, and/or 
ingestion of infectious rodent excreta as the primary route of transmission from 
rodent reservoir to human hosts.  Additionally, controlled experiments 
investigating intragastric (i.g.) versus intravenous (i.v.) routes of inoculation of 
non-human primates (NHPs) have continued transmission through these routes.  
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These studies utilized Lymphocytic Choriomeningitis Virus (LCMV)-WE, a strain 
of LCMV that results in Lassa Fever (LF)-like disease in NHPs, and LCMV-
Armstrong (ARM), a strain of LCMV that mimics subclinical infection.  When 
administered i.v., LCMV-WE-infected NHPs became systemically infected, 
showing clinical signs much like that of LF, and died.  However, when orally 
infected with this virus through i.g. inoculation, some of these animals recovered, 
and later, were protected from lethal doses of i.v. WE challenge. 
 Due to the nature of natural transmission from rodent to humans, epithelial 
cells are amongst the first cells to come in contact with the virus.  However, the 
role(s) of the epithelial barrier during these infections have yet to be investigated.  
In order to investigate the role of these cells during arenaviral infection, here, a 
cell culture model was developed to investigate the interaction of OW 
mammalian arenaviruses at the site of intragastric inoculation.  An important 
finding of this works is that the patterns of entry and release are viral dependent, 
and attachment to epithelial surfaces may play a role in these phenomena.  
Furthermore, regardless of their pathogenic potential in NHPs, both strains of 
LCMV, as well as LASV’s close relative, MOPV, showed similar patterns of entry 
and release when exposed to the apical and basolateral surfaces of polarized 
intestinal epithelia. Additionally, the replication patters of vaccine candidate ML-
29; a reassortant virus that contains the L segment of MOPV, and S segment of 
LASV, providing the exact same GP1 of LASV, were characterized.  Interestingly, 
ML-29 virus entered and released in a different pattern than was observed with 
LCMV and MOPV.   
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 To determine if patterns of viral entry and release were driven by 
attachment differences, LCMV, MOPV, and ML-29 viral attachment to the surface 
of polarized epithelia was analyzed.  LCMV an MOPV attaches to the apical and 
basolateral surfaces of the cells with similar efficiency.  However, ML-29 showed 
decreased attachment to the basolateral surface of these cells as compared to 
the apical surface.   
 Due to differences in pathogenicity seen in NHPs infected i.v. with LCMV-
WE and ARM, we hypothesized that these viruses would show differences in 
entry and release patterns in the polarized Caco-2 cells.  However, these viruses 
replicated in much the same way.  From these observations, we sought to further 
investigate differences in viral replication that may explain pathogenic differences 
between these closely related viruses.  To do so, we investigated intracellular 
trafficking under the hypothesis that it may be responsible for these differences. 
 Through the use of chemical inhibitors and immunofluorescence with 
confocal microscopy, a number of differences through the intracellular trafficking 
of LCMV-ARM and WE.  The data indicates that LCMV-WE bypasses the TLR-2 
receptor interaction in early endosome, and does not produce an IL-6 response 
in infected macrophages, opposed to LCMV-ARM-infected cells.  Additionally, 
co-staining with LCMV and late endosome marker RAB7, showed more co-
localization with LCMV-ARM than that of LCMV-WE.  Furthermore, when 
blocking acidification of late endosome/lysosome with bafilomycin treatments, 
LCMV-ARM was more sensitive to pH change in the late endosome, indicating 
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that fusion occurs at less acidic conditions.  These less acidic conditions promote 
earlier release at viral RNA in the case of LCMV-ARM versus that of WE. 
 Together, these results signify differences in viral replication are tissue 
and viral specific.  Furthermore, this research provides a platform to continue 
investigating key differences in viral replication between viruses of close genetic 
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OVERVIEW OF ARENAVIRIDAE 
Arenaviridae is a family of viruses that are known to cause asymptomatic, 
chronic infections of rodents, and human disease ranging from asymptomatic 
infection to deadly hemorrhagic fever. These viruses have been identified world-
wide, utilizing rodents as the host reservoir.  Arenaviridae gets its name from the 
term arenosus which is Latin for “sandy” due to their appearance in electron 
microscope sections, caused by ribosomes obtained from their infected host cells 
[1]. When these viruses are transmitted to humans, they can cause minor to 
severe infection that may lead to hemorrhagic fevers.  Others seem to be non-
pathogenic for humans, or rarely found in human hosts.   
Initially, arenaviruses were thought to only infect mammals, but recently, 
arenaviruses have been identified as the causative agent of inclusion body 
disease in the boid family of snakes [2]. These findings spurred a change in 
arenaviral taxonomy, leading to a new genus of arenaviruses; mammarenavirus, 
which utilize a mammalian host (Figure 1), and of genus reptarenavirus which 
target reptilian hosts [3].  Among the mammarenavirus genus, there is further 
division into the Old World (OW) or LCMV-Lassa virus complex, and the New 
World (NW), or Tacaribe virus (TCRV) complex [3, 4].  The mammarenaviruses 
are separated into the OW and NW complexes based on geographical location 
and genetic relatedness. The OW complex has a single lineage containing five 




Figure 1. Taxonomy of Mammarenaviruses. 
 Multiple sequence alignment of the complete GPC from different arenaviruses 
were analyzed via CLUSTALW analysis.  A phylogenetic tree was generated 
using MacVector 12.6.0.  Hoizontal distances represent protein differences. 
Viruses highlighted in blue represent viruses used in studies presented here. 





























Mobala virus, and Lymphocytic Choriomeningitis virus (LCMV), as well as some 
newly discovered viruses including Lujo, Morogoro, Dandenong, and Kodoko 
virus [6-8].  The NW complex has several lineages; clade A, B, C, and A/Rec.  
Clade A of the NW complex contains 5 species; Flexal mammarenavirus, Parana 
mammarenavirus, Pichinde mammarenavirus, Pirital mammarenavirus, and 
Allpahuayo mammarenavirus. Most of the NW viruses are not known to be 
pathogenic for humans, and are located in South America.  Arenaviruses of 
Clade B also reside in South America where viruses of Clade A are found.  This 
clade contains eight viruses including four in which are known to be significant 
human pathogens; Sabia virus, Guanarito, Junin, and Machupo virus.  Other 
viruses of this clade include Tacaribe, Chapare, Cupixi, and Amapari virus.  
Clade C is comprised of only two arenaviruses, Latino virus and Oliveros virus; 
both of which exist in South America and are not known to be pathogenic to 
humans.  Finally, Clade A/Rec is comprised of the virus species that are found in 
North America and are either pathogenic (Whitewater Arroyo virus) or non-
pathogenic (Tamiami virus, and Bear Canyon virus) for humans. 
THE ARENAVIRUS LIFE CYCLE 
 
During viral infection, binding with host receptors has been shown to be 
the signal that facilitates entry into the host cells [9].  The most common, and first 
to be discovered, cellular receptor used by OW arenaviruses, and clade C of the 
NW group, is alpha-dystroglycan (α-DG) [10, 11].  Dystroglycan is a cellular 
component found in most mammalian tissues, and is used as a linkage between 
the extracellular matrix (ECM) and the actin cytoskeleton of cells.  Αlpha-DG 
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normally binds a component of the extracellular matrix, laminin, while β-DG is the 
membrane portion of the receptor that anchors the receptor with its binding to 
dystrophin in the cytoplasm. Dystroglycan undergoes processing of the core 
protein that results in extracellular component, α-DG, and transmembrane protein 
β-DG.  During processing of DG, α-DG goes through a complex O-glycosylation 
process [12].  This process is essential for α-DG function as both a cellular 
component and receptor for arenaviruses [13, 14].  It has been shown that viral 
attachment is dependent upon modification of like-acetylglucosaminyltransferase 
(LARGE) of DG [15], and binding affinity is influenced by the length of these 
LARGE-derived glycans [13].  A genome-wide study of residents in Western 
Africa showed that there is a positive selection for specific LARGE alleles in 
these populations [16-18], indicating that DG modification may play a potential 
role in viral-host evolution.  However, it is still unclear whether or not these 
selections of LARGE alleles play any role in susceptibility or transmission of 
these viruses.  Rojek and colleagues have hypothesized that α-DG binding by 
LASV destabilizes the membrane due to its lack of binding to laminin, thus 
creating a disturbance in the membrane and intracellular signaling, contributing 
to LF disease pathogenesis [19].   
Not all arenaviruses bind α-DG with equal affinity.  Differences in receptor 
binding are also related to infection seen with LCMV; LCMV-WE 54 and LASV 
strains have a high affinity for α-DG, and cause persistent infection.  However, 
those with lower affinity, are readily cleared (e.g. LCMV WE HPI, WE2.2, and 
ARM) [10, 20-24].  Serine at position 153, and Leucine at position 260, have 
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been associated with high-affinity binding of α-DG [24-26]; however, LCMV-WE 
HPI encodes S153 and L260, but binds α-DG poorly, suggesting that additional 
residues may play a role in α-DG binding.  Hastie et al. identified that Y155 was 
also required for high-affinity binding to α-DG, as well as H136 and R190 [27].  
Additionally, this group investigated the role of full-length LCMV GPC or the GP1 
subunit.  Previous research has reported that LASV required full-length GPC to 
pull down α-DG and not GP1 alone [28, 29], and indeed, LCMV showed similar 
results [27].  
Along with α-DG, there have been reports of a number of alternative 
receptors that OW arenaviruses may utilize to attach to and enter into host cells.  
These receptors include cell surface receptor Axl and Tyro3/Dtk, both of which 
are Tyro3/Axl/Mer (TAM) tyrosine kinases; as well as C-type lectins DC-specific 
ICAM-3-grabbing nonintegrin (DC-SIGN) and LSECtin [30, 31].  Tyro3 and Axl 
are broadly expressed in a number of different mammalian tissues and are 
involved in the removal of apoptotic cells [32, 33].  Given the co-expression of 
viral receptors DG and TAM, this supports the idea that LASV and other OW 
arenaviruses appear to have an incredibly complex receptor usage, which is still 
not entirely understood.    
Once bound to α-DG, LCMV and LASV enters cells via a unique form of 
endocytosis that is clathrin, caveolin, dynamin, and actin-independent [34-38].  It 
has recently been discovered that when LASV binds, β-DG is phosphorylated, 
which results in dissociation of β-DG from the cytoskeleton and may be used in 
facilitating endocytosis [39].    Additionally, it has been recently been identified 
7 
 
that LASV and LCMV utilize sodium hydrogen exchangers (NHEs), indicating 
that viral entry is associated with micropinocytosis giving additional support for a 
micropinocytosis-like pathway [40].  The path of viral entry through 
micropinocytosis is not new to virology.  A number of other viruses including 
human papilloma virus (HPV-16), adeno-associated virus 2 (AAV2), and 
Influenza A virus (IAV) utilize a form of micropinocytosis during viral entry [41].  
Other factors associated with LASV entry include the need for GTPase Cdc23 
and the downstream effectors PAK1 and N-Wasp, however factors including 
Rac1, RhoA, the Arp2/3 complex, myosinII, and myosin light chain kinase are not 
essential during LASV entry [40].    
Many factors of LASV entry support the concept that LASV entry uses a 
unique form of micropinocytosis.  Macropinosomes, like those of early 
endosomes, must go through a maturation process [42].  However, the 
maturation process is not completely understood for LASV.  What is known, is 
that LASV passes through the late endosome on its path to replication [43], but 
the point in which LASV moves from a micropinocytosis pathway into the 
classical late endosome pathway is still unknown.  What has been identified is 
that delivery of the multivesicular body to the late endosome is dependent upon 
microtubular transport [35, 44].  The virus-receptor complexes are sorted into 
intraluminal vesicles with the help of ESCRT (endosomal sorting complexes 
required for transport) proteins to be transported to the late endosome [43].  This 
method of trafficking results in a bypassing of the early endosome, the 
compartment that contains TLRs responsible for recognizing viral RNA.  The 
8 
 
utilization of this trafficking system may provide pathogenic OW arenaviruses the 
ability to avoid triggering immune responses within host cells [45].  Once LASV 
has reached the late endosome, acidification causes LASV to switch from α-DG 
to an intracellular receptor, LAMP1 [28].   
Lysosome-associated membrane protein (LAMP) 1, is a protein that is 
partially responsible for the maintenance of lysosomal integrity at very low pH 
[46, 47].  Binding of LAMP1 is driven by a triad of histidines on the GP1 and that 
binding of LAMP1 triggers the LASV spike to catalyze membrane fusion by 
potentiating its response to pH [29, 48].  While this histidine triad is conserved 
among other OW arenaviruses, LAMP-1 utilization has been shown to be specific 
for LASV, and LAMP1 is not utilized by LCMV or other OW arenaviruses, 
regardless of α-DG affinity [27, 49].  Additionally, recent research has identified 
that LAMP 1 increases LASV efficiency during entry, and increases the pH of the 
late endosomes/lysosomes to promote replication [50].  While LAMP1, even in 
low amounts, supports robust entry of LASV, LAMP1 is not necessary for viral 
entry, although attenuation is seen without LAMP1 present [50].    
While there is not a complete understanding of viral assembly and 
budding of arenaviruses, the Z protein, or matrix protein, has been shown to be 
essential for budding progeny, as it is capable of forming virus like particles 
(VLPs) when expressed alone [51].  During the budding process, Z forms an 
inner layer under the viral envelope where it is able to recruit NP and GPC to the 
viral particles, and has been shown to require ESCRT pathway to be successful 
[52-55].  It does seem that one or more proline rich domains in the C-terminus, 
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and/or the YxxL motif in the RING domain need to be present in order for 
productive assembly to occur, however the number and combinations of these 
domains vary among OW arenaviruses.   
 
THE ARENAVIRUS GENOME 
 
 Arenaviruses are enveloped viruses, decorated with glycoprotein spikes 
on the outside, that have a single-stranded, negative-sense, bi-segmented RNA 
genome.  Arenaviral particles can range from 40 to 200 nanometers in diameter 
[6, 56].  One segment, the large (L) segment, encodes the small RING finger 
protein that serves as the matrix protein (Z), and the RNA dependent RNA 
polymerase [57]. The other segment, the small (S) segment, encodes 
nucleoproteins (NPs) and glycoproteins (GP) [57].  The viral genome uses an 
ambisense coding strategy, synthesizing two polypeptides in opposite 
orientation, which is separated by a noncoding intergenic region (IGR), with a 
hairpin structure which contains 2 segments (Figure 2 and 3).  The term 
ambisense was coined to describe the one region on both the S and L segments 
that were negative sense, and in a nonoverlapping region, the segments are 
pseudo-positive sense. Arenaviral RNA acts as the template for transcription and 
replication to occur.   
Due to the nature of the ambisense genome, the NP and L genes are 















Figure 2: Arenavirus virion structure. 
The Glycoprotein (GP) 1, responsible for attachment to cellular receptors, and 
GP2, responsible for fusion of host membranes, are depicted in dark and light 
purple, respectively. Beneath the viral envelope (dark blue) the matrix (Z) protein 
is depicted in green. Inside the virion are host ribosomes, that give arenaviruses 
their “sandy” appearance in electron micrographs, are depicted in gray.  
Additionally, ribonucleoprotein complexes are composed of nucleoprotein (NP- in 
red) that encapsidate viral RNA.  The ribonucleoprotein complexes are 
associated with RNA-dependent RNA polymerase (L) depicted in blue. Image 





Figure 3. Arenavirus Genome. 
The genes of the small (S) segment encode the glycogroptein complex (GPC-
purple) and Nucleoprotein (NP- red). The Matrix protein (Z), and RNA-Dependent 
RNA Polymerase (L-blue) are encoded on the Large (L) segment.  These genes 
on two segments that are arranged in ambisense orientation. Image adapted 
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must go through genomic RNA replication, and only then these genes are 
transcribed into mRNAs being translated into GPC and Z proteins.  Highly 
conserved regions at the 3’ end of both the L and S segments, suggests these 
are the site of viral polymerase initiation [58, 59].  Through the use of electron 
microscopy, scientists have observed that both the 5’ and 3’ ends of the L and S 
genome segments form panhandle structures thought to have a role in controlling 
RNA synthesis, and these arenavirus genomes and antigenomes show a high 
degree of complementarity between their 5’ and 3’ termini [60-63]  
Due to the inconsistency in the location of S-derived NP and GP 
transcription termination, it has been predicted that the structural motif, rather 
than the sequence of the IGR, is what promotes the release of viral polymerase 
from the template RNA [59, 61].  There are significant differences between the 
location of S and L IGR sequences in regards to RNA folding, however, among 
isolates and strains of the same species, S and L IGR sequences are highly 
conserved.  Viruses such as LASV and LCMV contain a single stem loop, 
whereas MOPV and TACV are predicted to have two [59, 64].  
The glycoprotein complex (GPC) is translated as a precursor polyprotein, 
which is translocated into the ER where a stable signal peptide (SSP) is cleaved 
from its N-terminus.  Further posttranslational modifications result in two 
subunits; the peripheral GP1 responsible for receptor attachment, and the 
transmembrane protein responsible for membrane fusion, GP2 [58].  The SSP 
remains associated with the GP1 and GP2 virion and serves several important 
functions.  One function is that the SSP is required for cleavage and maturation 
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of the GPC.  Additionally, the SSP associates with the transmembrane domain of 
the GP2, and potentially may play a role in pH-dependent fusion of the GP [27, 
65-73].  After arenaviruses enter the cell via a micropinocytosis-like pathway, the 
GPC is exposed to an acidic environment in the late endosome.  This pH change 
triggers irreversible conformational changes that the virus utilizes for fusion to 
host membranes.       
Previous work has determined that the GP1 from JUNV, LCMV, and 
MACV all have a similar core of a six-stranded β-sheet, and most of the helices 
on the helix-loop face are maintained between the three viruses [27].  The N- and 
C- termini of LCMV, MACV, and JUNV GP1 are oriented towards the GP1-GP2 
surface, LASV GP1 termini are oriented in the opposite directions [27].  
Additionally, these major helixes of LASV GP1 is nearly perpendicular to the 
orientation of these helices in LCMV, JUNV, and MACV GP1 [27]. 
The GP2 subunit contains both heptad repeats and fusion regions.  
Crystallization of GP2 subunits of arenaviruses show six-helix bundles structures 
that typically are found in the class I viral glycoproteins [74-76]. Research shows 
that LASV employs both an N-terminal fusion peptide (termed F1), like that of 
class I viral glycoproteins, and a fusion loop (termed F2), as seen in Ebola virus 
[77].  Interestingly, the amino acid sequences of these F1 and F2 are well 
conserved and nearly identical between the arenavirus family [27].  Additionally, 
there have been extreme differences between the post-fusion form of LCMV GP2 
and the pre-fusion form.  In post-fusion conformation, HR1 and HR2 form a 
single helix with a ‘T loop’ between them, and three copies of each HR1 and HR2 
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form an antiparallel 6-helix bundle.  In the pre-fusion GP2, HR1 is broken into 4 
different segments, HR1a, HR1b, HR1c, and HR1d.  HR1a, c, and d form 
discrete helices, while b forms an extended loop structure.  Additionally, the T 
loop forms two anti-parallel β strands, rather than an α-helix observed in post-
fusion structures [27].  These conformational differences suggest that GP2 
conformational rearrangements occur in the T loop and in the heptad repeat 
regions during entry.            
 
INDIVIDUAL VIRUSES OF MEDICAL CONCERN 
LASSA VIRUS 
 
Though Arenaviridae is a highly diverse group of viruses, the most 
significant of the OW group is Lassa virus (LASV).  LASV is the most pathogenic 
of the OW arenaviruses, and is responsible for several hundred thousand 
infections, and thousands of deaths annually in Western Africa [45, 78-80].  
Although most individuals exposed to LASV mount an immune response to 
defend against disease, LASV causes a significant number of deaths annually.  
Interestingly, over 45% of the populations in some villages of endemic regions is 
seropositive for LASV, but it is not well understood why some of the population 
succumb to disease and others do not [81].  LASV is carried by its natural host 
Mastomys natalensis. While transmission to human is not completely 
understood, it is widely accepted that it likely occurs via ingestion of 
contaminated food-stuffs, or by the inhalation of infectious particles [45].  The 
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rodent reservoir for LASV and other OW arenaviruses has been shown to 
maintain low viral titers without presence of disease onset [82].   
LASV is designated by the Centers for Disease Control and Prevention as 
a category A agent due to its high lethality and transmissibility via aerosols.  
Currently, ribavirin is the only treatment available for LASV, but caveats to this 
antiviral strategy include severe side effects, and a requirement for early 
administration in order to have positive effects on LASV disease [83].  Currently, 
there are no clinically approved vaccines for Lassa virus. Among several vaccine 
candidates, a MOPV/LASV reassortant (clone ML-29) has demonstrated safety 
and high efficacy in all available animal models including immunocompromised 
NHPs [84-90].  ML-29 is a reassortant virus between two unrelated arenaviruses 
created in vitro after co-infection of cells with both LASV and Mopeia virus 
(MOPV).  Specifically, ML-29 is composed of the L segment of MOPV and the S 
segment of LASV [91].    
Diagnosing LASV in the early stages of infection is difficult as LASV 
disease can often be misdiagnosed for other co-endemic infections such as 
malaria or influenza [92].  Disease manifestation of LASV can range from non-
symptomatic subclinical illness, to organ failure and even death.  A number of 
signs and symptoms may be observed from LASV-infected patients including 
fever, malaise, nausea, petechial hemorrhage, vomiting, diarrhea [93, 94]. 
Interestingly, sensorineural hearing loss has been observed in up to one-third of 
patients [95].  Infections with fatal outcomes often exhibit encephalopathy, 
mucosal bleeding, shock, and coma [93, 96, 97].   
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While LASV results in the most infections and deaths of the OW 
arenaviruses, the underlying pathogenic mechanisms and virulence factors are 
still poorly understood.  One predictor of disease survival is the level of viremia.  
Patients that have a higher load of LASV often have poor prognosis and show 
exacerbated signs and symptoms of disease [98].  Viremia higher than 3.5 log 10 
TCID 50, typically result in death [21, 96].  Alternatively, patients that display a 
low level of viremia tend to survive [98].  While LASV can cause hemorrhagic 
manifestations, the death related to LASV is far from typical hemorrhaging due to 
tissue damage.  LASV replicates to high titers in vital organs including the liver, 
lung, and spleen, however, any histological damage in these organs is not 
severe enough to cause death.  The most common and consistent infection-
associated lesions are seen on the liver of infected patients, and consist of 
hepatocellular necrosis, mononuclear phagocytic reaction, and focal 
hepatocellular cytoplasmic degeneration, with a very small amount of immune 
infiltration [99].  Nonetheless, even these pathological lesions are insufficient to 
cause death in these Lassa Fever (LF) patients [99]. 
LASV, unlike other hemorrhagic fevers, does not cause severe 
hemorrhaging in infected individuals.  In the minority of patients that exhibit 
hemorrhaging, it is mostly present at mucosal surfaces [45].  Thus the amount of 
blood loss and tissue damage is not sufficient to result in shock and death 
observed in lethal cases [99].  When significant bleeding does occur, usually 
thrombocytopenia and platelet dysfunction are co-observed [100, 101].   
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LASV has a non-lytic life cycle, and has been shown to not induce cell 
death in infected macrophages, endothelial cells, and monocytes [102].  Vascular 
endothelium has been shown to be permissive to LASV, resulting in high titer 
production of virus, and death of these cells was not observed [102].  
Experimentally infected NHPs, as well as human patients, have shown signs of 
vascular distress and permeability, followed by shock and death [99, 103].  
Although human and NHPs infected with LASV do not show lesions in vascular 
tissue, vascular permeability is present during infection.  The mechanism leading 
to vascular permeability has yet to be identified, but is hypothesized to be caused 
by LASV manipulating normal cellular functions of the endothelial tissue, which 
results in increased fluid leakiness from these tissues.  Immune regulators are 
likely the culprit of this increased permeability of tissue, as such is observed with 
hemorrhagic fever viruses Ebola (EBOV) and dengue (DENV) [104].  However, 
LASV does not share the same cytopathic profile, but rather has low levels of IL-
8 and interferon (IFN)-inducible protein (IP)-10 [105].  In vitro macrophages and 
dendritic cells (DCs) are not able to be activated when infected with LASV and 
pro-inflammatory markers are not released [106, 107], and pro-inflammatory 
cytokines are not detected in the sera of fatally infected LASV patients [105].  
Interestingly, human umbilical vein endothelial cells (HUVECs) exposed to LASV 
responded with no change in IL-8 production, a feature commonly seen in LASV 
patients.  However, when apathogenic MOPV, a close relative to LASV, infected 
these cells, IL-8 was produced in significant amounts [102], indicating LASV’s 
ability to downregulate innate immune responses.      
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LYMPHOCYTIC CHORIOMENINGITIS VIRUS 
 
Due to LASV’s status as a Category A biothreat, LCMV is the prototypic 
arenavirus utilized to study many aspects of arenaviral pathogenicity. LCMV was 
originally discovered in 1933 when it was the first arenavirus to be isolated during 
an encephalitis epidemic in St. Louis [108].  After its isolation, it soon was 
associated as the agent that was chronically infecting mouse colonies [109] as 
well as causing aseptic meningitis in humans [110].  LCMV is an OW mammalian 
arenavirus that can be found worldwide, partly due to its reservoir, the house 
mouse.  This virus can be transmitted vertically in mouse populations via 
intrauterine infection.  These mice that are infected in utero are unable to mount 
an immune response to LCMV, which leads to development chronic, 
asymptomatic, life-long infection, and the ability to shed virus in large quantities 
through bodily secretions [111].    
LCMV’s natural reservoir is the house mouse, mus musculus, and LCMV 
can infect humans who come in contact with rodent secretions.  While direct 
human-to-human transmission has not been observed, LCMV infection may be 
transmitted through solid-organ transplantation, and from an infected mother to 
her fetus [8, 112-114].    While the house mouse is the natural reservoir for 
LCMV, other rodent species are capable of being infected with the virus.  For 
instance, the largest outbreak of LCMV occurred in the US where 181 humans in 
12 different states came in contact with hamsters from a single distributor that 
were infected with LCMV [115, 116].  LCMV has infected approximately 5% of 
the human population in the US [117-120], and higher seropositivity rates in other 
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areas of the world, including over 36% in Croatia and Bratslavia in Slovakia [121, 
122].  Additional countries and regions have been assayed for LCMV 
seropositivity including Nova Scotia [123] and North and South Germany [124].  
Additionally, countries including Argentina [125], Spain [126], and Italy [127] have 
measured seropositive human populations (1%-2.5%) and rodent populations 
(5.6-12.9%).   
When humans become infected with LCMV, the infections are often 
asymptomatic or mild, resulting in fever, chills, nausea, vomiting, myalgia, and 
headache. Typically,  1-3 weeks after infection, it resolves itself without treatment 
[58].  Due to most LCMV cases being minor or having no symptoms associated 
with them, the true incidence of LCMV infections is not known, but based off of 
the seropositivity data available, it is presumably low [128].  However, in a 
minority of the population, progress into aseptic meningitis or 
meningoencephalitis, with potential for additional neurological complications 
including transverse myelitis, Guillain-Barre-type syndrome, hydrocephalus and 
sensorineural hearing loss [129]. While neurological symptoms are most 
common, non-neurological symptoms including pancreatitis, orchitis, arthritis, 
parotitis, and pericarditis, have been reported [130].  While these symptoms have 
been reported, most adults infected with LCMV fully recover, and fatality is 
exceptionally rare [131].   
 LCMV infections in healthy individuals are usually not dangerous; 
however, in immune compromised individuals, LCMV can produce a disease that 
closely resembles LF [58].  There have been 17 cases of reported LCMV 
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infections in transplant recipients, 14 of which were fatal [8, 113, 114, 131].  
Infection from transplantation has been associated with multisystem organ failure 
and hepatitis.    
While the mortality rate of LCMV is less than 1% [131], some LCMV 
infections can be serious, resulting in spontaneous abortion if pregnant women 
are infected during the first trimester [132, 133].  Infection in the second and third 
trimester has been linked to congenital neurological dysfunction including 
hydrocephalus, macro- or microcephaly, gyral dysplasia, focal cerebral 
destruction, loss of vision, and chorioretinitis [130, 132-136]. True prevalence of 
congenital LCMV infection is unknown, due to the similarity to cytomegalovirus 
infection and congenital toxoplasmosis, but it is estimated that 35% of infants die 
from complications of congenital LCMV. 
 
TRANSMISSION OF RODENT-BORN ARENAVIRUSES TO HUMANS 
 
Transmission of arenaviruses from their natural rodent reservoirs to 
human hosts has been identified to occur via routes of ingestion of contaminated 
food stuff or inhalation of infectious particles [45, 137]. An epidemiological study 
in the Republic of Guinea showed a link between the consumption of 
contaminated food as a risk factor for rodent-to-human transmission [137].  There 
have been some in vitro studies investigating arenavirus interactions in culture 
models of kidney and bronchial epithelia [138, 139].  However, there has yet to 
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be in vitro investigation using cell types representative of the sight of intragastric 
infection.    
During rodent-to-human transmission, epithelial cells of the 
gastrointestinal system and upper respiratory tract are among the first host cells 
to come into contact with the viral pathogen.  Transmission via aerosolized viral 
particles is generally considered to be initiated by the interaction of the virus with 
the apical side of the epithelia, whereas viruses that are transmitted via scratch 
or bite from an infected host is interacting directly with circulating blood cells or 
the basolateral sides of epithelial cells [139-141].  The route exposure can alter 
infection due to receptor location, resulting in difference entry and adherence to 
cells. In addition, epithelial polarization has been shown to impact the location of 
viral receptors [138, 142-144].  Interestingly, infection of different organ tissues 
has resulted in differences in entry and exit patterns, as seen with infection of 
thyroid and colon cell lines with Semliki forest and Sindbis viruses [145].   
Additionally, members of the same virus family have shown opposing results in 
replication within the same tissue [146], making transmission of viruses even 
more unclear. 
 
IMMUNE RESPONSE TO OW ARENAVIRAL 
 
When humans do become infected with LASV, a T-cell mediated response 
to LASV seems to be critical in survival [147-150].  In NHP studies, animals that 
survived LASV infection showed T-cell activation to be one key to survival, as 
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monkeys that showed a delay in T-cell activation (as well as a high viral load), did 
not survive [151].  Clinical observations indicated that the antibody response 
does not seem to be effective in controlling LASV infection, indicating that 
antibodies produced against LASV, are non-functional and not neutralizing 
antibodies.  This inability to control viral infection may be a result of NK cells or 
downregulation of cytotoxic T-cell populations, both of which have yet to be 
investigated in patients with LF. The levels of antibodies in sera did not correlate 
with recovery or progression, signifying that these antibodies are not functional or 
capable of neutralizing viral activity  [98]. 
Macrophages and antigen presenting cells (APCs) are the first cells to 
come in contact with the virus after the virus crosses the epithelial barrier.  
Notably, in an in vitro study, LASV was seen to readily infect human dendritic 
cells (DCs) and macrophages, but was unable to activate these cells [106].  This 
was signified by lack of increase in several immune mediators including tumor 
necrosis factor alpha (TNFα) and interleukins such as IL-1β, IL-6, or IL-19, as 
well as the absence of costimulatory molecules such as CD40, CD54, CD80, 
CD86, or HLAs; all of which signify a lack of DC phagocytic activity [106].  A 
recent study however, has compared levels of pro- and anti-inflammatory 
cytokines and chemokines from the serum of LASV-infected patients [105].  
These samples included serum from LASV-infected humans fatally-infected and 
non-fatally-infected, as well as uninfected control samples.  Interestingly, pro-
inflammatory markers IL-8 and interferon-inducible IP10 protein, were 
significantly higher in patients with non-fatal LASV infections than in control 
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samples.  However, patients with fatal LASV infections, had little or undetectable 
levels of IL-8 and IP10.  Also notable, that although TNFα concentrations were 
not elevated in any of the LASV-infected patients, those patients did show an 
increase in TNFα receptors compared to uninfected individuals.  Additionally, IL-6 
has been noted as an important factor for determining the outcome of patients 
infected with LASV [98].  IL-6 has been seen to be abundant in fatally infected 
NHPs as well as humans, and along with elevated liver enzymes, aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT); all potential 
biomarkers for progressed LASV infection [90, 98, 151-156].   
Mopeia virus (MOPV) is genetically a close relative to LASV; however, 
MOPV lacks pathogenic potential in humans and non-human primates, and 
induced protective immune responses against LASV challenge in NHPs [149].  
MOPV, like LASV, lacks the ability to activate DCs in vitro, however, MOPV is 
able to activate macrophages, as signified by increases in the transcription of 
several immunoregulatory genes for interferon alpha (INFα), IFNβ, TNF and IL-6 
[157].   
An effective innate response to viral infection, that results in an adaptive 
response, is essential for the control and prevention of disease manifestation.  
Additionally, strong activation of these responses is typical of non-pathogenic 
arenaviruses [102, 158-162]. However, LASV is known for its suppression of 
immune systems in infected patients.  One mechanism in which OW 
arenaviruses do this is by preventing type I IFN production.  Several studies have 
shown that LASV NP may be responsible for inhibiting type I IFNs, related to the 
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establishment or maintenance of persistent infections in natural rodent 
reservoirs.  These NPs result in silencing of innate and adaptive-immune 
responses by degrading double-stranded RNAs (dsRNAs) [163, 164].   dsRNAs 
act as pathogen-associated molecular patterns (PAMPs) and have been shown 
to trigger several different proteins such as RIG-I and MDA5, both of which 
trigger an antiviral signaling cascade [165, 166]. Notably, NP of tacaribe virus 
(TCRV), a virus isolated from ticks with no identified mammalian host, does not 
inhibit IFN type I response [54].  
Additionally, LCMV-WE and LASV have been shown to down-regulate 
innate pro-inflammatory responses in vitro, and in vivo, compared to non-
pathogenic LCMV-ARM and MOPV [90, 102, 153, 156, 167].  LCMV-WE and 
LASV-infected cells inhibited Toll-like receptor 2 (TLR2)/MyD88 adaptor-like 
(Mal)-dependent cytokines.  In contrast, LCMV-ARM and MOPV induced NF-κB-
mediated proinflammatory responses in monocytes, macrophages, and in 
epithelial cells [167].  Interestingly, previous research has shown that 
internalization and viral replication is required for the TLR2/Mal-dependent 
signaling.  When cells were exposed to UV- or heat-inactivated LCMV-ARM, the 
cells did not induce TLR2/Mal-dependent pro-inflammatory cytokines [167], 
indicating that successful viral infection needs to occur, and not just interaction 
with viral receptors and the host.  
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ANIMAL MODELS MIMICKING NATURAL TRANSMISSION 
 
 
Natural transmission from rodents to human hosts occurs through 
ingestion or inhalation of contaminated food stuffs or aerosolized infectious 
particles.  Studies in mice and NHPs, using inhalation and ingestion routes of 
infection provide insights to arenaviral transmission [155, 168, 169].  Mice that 
were treated intravenously (i.v.) had viral dissemination of LCMV within 72 hours 
post infection.  When infected intragastrically (i.g.), mice showed a delay of 
dissemination, but by 96 hours post infection, all tissues that showed positive 
infection via i.v. were positive in the i.g. infected mice as well [170].    NHPs 
infected either via i.g. or i.v. with LCMV-Armstrong (ARM) or LCMV-WE had 
differential infections.   LCMV-ARM produces a sub-clinical infection when 
administered to NHPs intravenously, as compared to LCMV-WE in which animals 
succumb to fatal infection with LF-like hepatitis and hemorrhage manifestations.  
Interestingly, when infected i.g. with a lethal dose of LCMV-WE, some monkeys 
recovered from manifested infection [171].  Interestingly, when these NHPs were 
challenged with a lethal dose of LCMV-WE after being intragastrically infected 
with LCMV-ARM or -WE, these animals did not succumb to LF-like disease as 
seen with PBS pre-treated animals [171].  Therefore, intragastric infection of 
NHPs with LCMV resulted in limited viral dissemination, that led to protective 
immunity. While animal models have been deployed to further characterize 
arenavirus pathogenicity several questions remain, and there is a need for an in 
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vitro model for studying interaction of mammalian arenaviruses with epithelial 
cells derived from major gates of virus entry. 
 
POLARIZED EPITHELIAL MODELS 
 
While there have been in vivo studies mimicking natural routes of 
infection, an in vitro system has yet to be developed to investigate the interaction 
of virus with intestinal epithelia at the site of intragastric inoculation.  Caco-2 cells 
have been an established model of intestinal epithelial cells for some time.  The 
cells were isolated from a gastrointestinal tumor by Jorgen Fogh in the 1970s 
[172].  Although many cell types had been isolated from tumors, these cells were 
different due to their ability to spontaneously differentiate upon reaching 
confluence. Upon further investigation in these cells, Caco-2 cells were found to 
mimic, quite closely, enterocytes of humans.  These cells started to polarize once 
confluency was reached, and developed characteristics that other cell lines did 
not provide.  Caco-2 cells are commonly grown on permeable filter inserts.  
These inserts allow the cells to obtain morphological and function characteristics 
of enterocytes [173]. Over time, Caco-2 cells change in dimension, growing taller 
and width of these cells decreased, moving to a more enterocyte-like cell [173].  
Additionally, via electron microscopy, after three days occluding junctional 
complexes were formed; and by day 6, desmosomes were formed and the lateral 
membranes of neighboring cells were interlocking.  Additionally, the formation of 
the brush border and microvilli were becoming more organized and numerous.  
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By day 16, these Caco-2 cells had formed a monolayer with a morphology similar 
to that of simple columnar epithelium of the small intestine.  Additionally, an 
increase in the amount and location of alkaline phosphatase, sucrase, and 
aminopeptidase was observed as the monolayers polarized [173, 174].      
In addition to morphological studies, functional studies have also been 
investigated, such as transepithelial electrical resistance (TEER) being 
measured.  TEER is a way to test the integrity of the Caco-2 monolayers by 
measuring the resistance across the membranes.  TEER measurements 
increased over time as these cells polarized on inserts, suggesting a confluent 
monolayer had been formed [173].  Furthermore, transport studies can also be 
done to test the permeability of this monolayer.  Several studies have 
investigated the permeability coefficients and absorption data in humans 
compared to Caco-2 cell lines and found high correlation between the two [175-
178].  Not surprisingly, the transport of molecules slowed as time of polarization 
of these cells increased, signifying that monolayer formation and integrity 
increased over time.  
While Caco-2 cell characteristics closely mimicked that of enterocytes, 
these cells did possess some characteristics of colonocytes [179].  Interestingly, 
while these cells were found as a tumor in the colon, it has yet to be explored as 





OBJECTIVE OF DISSERTATION 
 
LASV is the most pathogenic of the OW arenaviruses infecting thousands 
of people annually through ingestion of contaminated food stuffs or inhalation of 
infectious particles.  However, the role of the intestinal epithelial cells at the site 
of intragastric infection has yet to be explored.  Furthermore, factors determining 
differences in viral pathogenesis between close genetic relatedness has yet to be 
determined.  Collectively, the current studies show support that viral 
dissemination and interaction with epithelia may be host, tissue, and viral 
specific.  We explored these topics with the following aims: 
1) To investigate the interaction of LCMV-ARM, LCMV-WE, Mopeia virus 
(MOPV), and a reassortant virus simulating LASV, ML-29, with 
polarized intestinal epithelial cells mimick the role of barrier systems in 
arenaviral infection.   
2) To characterize differences between pathogenic and non-pathogenic 
strains of LCMV, Armstrong and WE respectively, during intracellular 
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Mammarenaviruses are single-stranded RNA viruses with a bisegmented 
ambisense genome. Ingestion has been shown as a natural route of transmission 
for both Lassa virus (LASV) and Lymphocytic choriomeningitis virus (LCMV). 
Due to the mechanism of transmission, epithelial tissues are among the first host 
cells to come in contact with the viruses, and as such they potentially play a role 
in spread of virus to naïve hosts. The role of the intestinal epithelia during 
arenavirus infection remains to be uncharacterized. We have utilized a well-
established cell culture model, Caco-2, to investigate the role of intestinal 
epithelia during intragastric infection. We found that LCMV-Armstrong, LCMV-
WE, and Mopeia (MOPV) release infectious progeny via similar patterns. 
However, the reassortant virus, ML-29, containing the L segment of MOPV and S 
segment of LASV, exhibits a unique pattern of viral release relative to LCMV and 
MOPV. Furthermore, we have determined attachment efficacy to Caco-2 cells is 
potentially responsible for observed replication kinetics of these viruses in a 
polarized Caco-2 cell model. Collectively, our data shows that viral dissemination 
and interaction with intestinal epithelia may be host, tissue, and viral specific. 
INTRODUCTION 
 
Arenaviruses are enveloped viruses that have a single-stranded, 
bisegmented, ambisense RNA genome. The Large (L) segment, encodes the 
matrix protein (Z), and the RNA dependent RNA polymerase [57]. The Small (S) 
segment, encodes the nucleoproteins (NPs) and glycoproteins (GP) [57].  
31 
 
Initially, arenaviruses were thought to only infect mammals; however, recently 
arenaviruses have been identified as the causative agent of inclusion body 
disease in the boid family of snakes [2]. Hence, Arenaviruses have been 
separated into two genera on the basis of their natural reservoir hosts; 
mammarenavirus, which infect mammalian hosts, and reptarenavirus which 
infect reptilian host species [3]. Among the mammarenavirus genera, there is 
further subdivision into the Old World (OW) LCMV-Lassa virus complex and New 
World (NW), Tacaribe virus complex [3, 4]. 
Lassa virus (LASV), the causative agent of Lassa fever (LF), is recognized 
as the most prevalent and most pathogenic of the OW arenaviruses. Annually in 
Western Africa, there are several hundred thousand clinical LASV infections, and 
thousands of deaths due to LF [45, 78-80]. Although LASV causes a significant 
number of deaths, the majority of infections are apparently subclinical, or not 
severe enough to warrant emergency medical intervention, as over 45% of the 
population in endemic regions is seropositive for LASV; however, why some of 
the population develop disease and others do not it is not well understood [81]. 
Most recently, a study of almost 200 LASV sequences has shown that reservoir-
to-human transmission is a primary driving force of LASV epidemics in Western 
Africa [17]. LASV is carried by its natural host Mastomys natalensis, and it is 
widely accepted that transmission of LASV to humans likely occurs via the 
ingestion of contaminated food-stuffs, or by the inhalation of infectious particles 
[45]. Indeed, an epidemiological study in the Republic of Guinea showed a link 
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between the consumption of contaminated food as a risk for rodent-to-human 
transmission [137]. 
Due to its high lethality and transmissibility via aerosols, LASV is 
categorized by the Center for Disease Control and Prevention as a category A 
select agent. Currently, there are no clinically approved vaccines for LASV; and 
the antiviral drug ribavirin is the only treatment available for LASV infection. 
Nonetheless, caveats to this antiviral strategy/treatment regimen include severe 
side effects, and the requirement for early administration in order to have positive 
therapeutic effects [83]. Among limited vaccine candidates, only a LASV/Mopeia 
(MOPV) reassortant virus, ML-29, has been demonstrated to induce protective 
immunity against LASV strains from clade IV (Sierra-Leone, Liberia, Republic of 
Guinea) and clade II (Nigeria) [84-90]. Specifically, ML-29 is composed of the 
MOPV L segment, a non-pathogenic relative of LASV, and the S segment of 
LASV [91]. MOPV and ML-29 share the L RNA encoding L protein (RNA 
polymerase), and Z protein (matrix). Previous studies have determined that the L 
RNA segment of MOPV is the major factor of ML29 attenuation in vivo. 
Comparison of the ML-29 L segment with the parental MOPV L segment 
revealed the presence of numerous point mutations that may contribute to the 
attenuated phenotype associated with ML-29 [85]. While this reassortant has ML-
29 specific mutations in the NP and GP2 proteins encoding by LASV S RNA, the 
attachment glycoprotein, GP1, is genetically identical to LASV. 
Similar to LASV, the prototypic arenavirus Lymphocytic Choriomeningitis 
virus (LCMV), is genetically and biologically diverse. Transmission of this virus 
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has been shown to share a similar mechanism to LASV, with transmission from 
rodents-to-non-human primates (NHP) and humans. Like the epidemiological 
study from the Republic of Guinea, a natural route of infection was observed 
within zoo kept tamarin populations, as animals that consumed LCMV-infected 
mice succumbed to LF-like illness and disease [180, 181]. Importantly, these 
results have been recapitulated experimentally via the intragastric inoculation of 
NHPs with LCMV [155, 182]. 
As mentioned earlier, LCMV strains are genetically and biologically 
diverse. LCMV-Armstrong (LCMV-ARM), a neurotropic strain, is highly adapted 
for infection in murine models. As such, exposure of NHPs to LCMV-ARM 
through either intravenously (i.v.) or intragastrically (i.g.) routes produced deeply 
attenuated sub-clinical infection [155, 182]. In contrast, LCMV-WE has limited 
passage history in mice and tissue culture models of infection, and induced fatal 
LF-like disease in i.g. and i.v. infected NHPs, providing a surrogate model of LF 
at biosafety level (BSL)-3 containment [155, 182]. Notably, infections via mucosal 
(i.g.) inoculation were attenuated during interaction with, and/or crossing the 
mucosal barrier of the gastrointestinal tract. Therefore, the intestinal epithelial are 
likely one of the natural gates of rodent-to-human transmission. Interestingly, 
when the LCMV-ARM or -WE i.g. infected NHPs were challenged with lethal 
doses of LCMV-WE intravenously, the animals did not succumb to LF-like 
disease as observed with PBS pretreated animals [182]. 
Due to the mechanism of transmission of arenaviruses from rodents to 
humans, epithelial tissue are among the first host cells to come in contact with 
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the viruses, and as such they potentially play a decisive role in the spread of 
virus to naïve hosts [183]. The role of epithelial barriers on infection has been 
investigated extensively with a number of other viruses; however, the specific 
role of the intestinal epithelia on arenavirus infection remains to be exhaustively 
characterized [138, 142-144]. Natural transmission via the intragastric route is 
generally considered to initiate with the interaction and infection of the epithelial 
cells from the apical side, whereas basolateral exposure of viruses requires 
damage, layer such as from a scratch or bite from an infected host, to the 
epithelial cell layer [139-141]. Here, we investigated the interaction of LCMV-
Arm, LCMV-WE, Mopeia virus (MOPV), and the LASV/MOPV reassortant ML-29 
with polarized Caco-2 intestinal epithelial cells, to investigate the role of barrier 
systems in viral dissemination, and to further elucidate the interactions of OW 
mammarenaviruses with the gastrointestinal epithelial. Collectively, our current 
studies support the model that viral dissemination and interaction with epithelia 
may be host, tissue, and viral specific. 
METHODS 
 
Viruses and Titration Assays.  VeroE6 (C1008) cells, Caco-2 (HTB-37) cells, 
purchased from American Type Culture Collection (ATCC), 16HBE140 cells (a 
gift from Jonsson Lab, The University of Tennessee Health Science Center), and 
Madin-Darby Canine Kidney (MDCK- a gift from Chung Lab, University of 
Louisville) were grown in minimal essential media using Dulbecco’s modified 
eagle medium (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine 
serum (Fisher Scientific, Hampton, NH, USA) and 1% antibiotic-antimycotic (Life 
35 
 
Technologies, Carlsbad, CA, USA) in a humidified chamber at 37 °C under 5% 
CO2. HBE cells were seeded on plates and flasks coated in a collagen, 
fibronectin solution containing the following concentrations in a 100mL solution: 
88mL of LHC basal medium (Invitrogen), 10mL bovine serum albumin 
(1mgBSA/mL LHC media), 1mL of Vitrogen 100 (BD Biosciences), 1mL Human 
Fibronectin (BD Laboratories).   
Cells were infected with LCMV-Armstrong (strain 53b), LCMV-WE (strain 
54), Mopeia virus (MOPV, strain AN20410), or the Mopeia/Lassa reassortant 
virus, clone ML-29 [184, 185]. All viral stocks were generated using low 
multiplicity of infection (MOI) and stocks with titers ranging from 1 × 107 PFU/mL 
to 1 × 108 PFU/mL were stored at −80 °C until needed [88]. 
Viral titers were determined using a standard plaque assay with minor 
modifications [167]. Briefly, VeroE6 cells were seeded in the wells of a 12-well 
cell culture plate, and incubated until 80–90% confluent. Virus samples were 
serially diluted, and used to infect the Vero cells. Infection was carried out for 1 h 
in 37 °C. After this period, the cells were washed with DMEM without phenol red, 
and a semi-solid overlay containing 1X MEM, 5% FBS, and 0.5% Avicel (FMC 
BioPolymer, Philadelphia, PA, USA) (LCMV and ML-29) or 0.5% Agarose 
(MOPV). Cells were then incubated in a 37 °C humidified chamber with 5% CO2 
for 5 days. The plaque assay cells infected with LCMV and ML-29 had the 
overlay media removed, were fixed with 4% paraformaldehyde solution for 15 
min and cells were stained with 1% Crystal Violet solution to identify virus-
infected cell foci. For titration of MOPV, virus-infected cells were covered with 
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semisolid overlay of 0.5% agarose/5% FBS overlay. A 0.04% neutral red, 0.5% 
agarose, 5%FBS solution was added to wells after 4 days incubation. Both 
plaque assays have a limit of detection of approximately 80 PFU/mL. 
Polarization of Caco-2 Cells and Infection of Polarized Cells.  Caco-2 cells 
were seeded on 24-well plate Transwell inserts (Corning, New York, NY, USA) 
with a 0.45 micron filter as previously described [173, 186]. Briefly, 160,000 cells 
in 0.5 mL were plated on “apical” side of insert, and 1 mL of nutrient media was 
added to each well. For basolateral seeding of the Caco-2 cells, the Transwell 
inserts were flipped upside down in a sterile container, and 0.5 × 106 cells in a 
volume of 100 µL was placed on each Transwell surface. The cells were 
incubated for 1 h at 37 °C to allow for adherence to the membrane. Cells were 
then put back into the 24-well plate and 0.5 mL of nutrient media was added to 
each insert. Cells were maintained at 37 °C in 5% CO2 for 21 days until 
polarization was completed. Media was changed every 2–3 days with fresh 
media for the entirety of the polarization process. To determine if polarization of 
epithelial monolayers was complete, Transepithelial Electrical Resistance 
(TEER) was measured with an EVOM2 Epithelial Voltohmmeter (World Precision 
Instruments, Sarasota, FL, USA) as previously described [187]. In experiments 
with non-polarized Caco-2, cells confluent monolayers on day 3 after seeding 
were used. Tight junction proteins were analyzed with western blot (WB) and 
qRT-PCR. Antibodies for WB were obtained from the following: ZO-1 (61-7300), 
Claudin-1 (Thermo Scientific 51-9000, Waltham, MA, USA), Occludin (Thermo 
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Scientific 71-1500). Pre-made primers/probe sets against human ZO-1 
(Hs01551861) and Occludin (Hs00170162) were purchased from ThermoFisher. 
Polarized Caco-2 cells were infected either apically, or basolaterally, with 
an MOI of 0.3 PFU/cell of the corresponding viruses: LCMV-Arm, LCMV-WE, 
MOPV, or ML-29. Wells and inserts were washed two times with DMEM without 
phenol red. To each insert, virus was added, and 1 mL of DMEM without phenol 
red was to each well. Infection was carried out for 1 h at 37 °C in 5% CO2. After 
this period, the inserts and wells were washed two times with 1x DPBS 
(Invitrogen), and 1 mL of nutrient media was added to each well and 0.5 mL was 
added to each insert chamber. Cells were maintained at 37 °C in 5% CO2. TEER 
was measured daily for 5 days, and the tissue culture supernatants from the 
Transwell inserts and wells were harvested daily and the media was replaced. 
 
Confocal Microscopy.  Caco-2 cells were grown apically on 12-well, 0.45 µM 
Transwell inserts (Corning) for 21 Days until a polarized monolayer was formed. 
Cells were then fixed with ice-cold methanol for 10 min at −20 °C, washed and 
stained on both the apical and basolateral sides of the inserts with antibodies 
against ZO-3 using monoclonal antibody against zonal occludin-3 (Cell Signaling, 
cat. # 3704, Danvers, MA, USA) at a 1:1600 dilution. Alpha-dystroglycan (α-DG) 
antibody clone 11H6C4, recognizing fully glycosylated α-DG, was used at a 
1:100 dilution (Milipore, cat. # 05-593, Billerica, MA, USA). Hoescht 33342 
(Thermo Fisher Scientific) was used for nucleus staining at 1:10,000 dilution was 
added for 10 min. Transwell filters were cut out and placed on microscope slides, 
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followed by 10 uL of ProLong Gold (Life Technologies), and a cover slip placed 
on top. Slides were analyzed using an Olympus FV1000 laser scanning confocal 
microscope and analysis was done using IMARIS software (Bitplane, Version 
7.7.1, Zurich, Switzerland). 
 
Attachment Assay.  Caco-2 cells were seeded and polarized for 21 days. Cells 
were infected with an MOI of 0.3 PFU/cell on either the apical, or basolateral, 
surface of polarized cells for all viruses. The cells were infected at 4 °C for 1 h to 
allow cells to attach to the cell surface, but not penetrate the cell. After the 
attachment period, the Input samples consisting of the cells and inoculum were 
directly harvested, and the experimental cells were washed several times with 
1xPBS to remove unbound virus particles. Trizol-LS (Invitrogen) was used to 
harvest all of the aforementioned cells. RNA was isolated according to the 
manufacturer’s directions. Quantitative Real-Time Polymerase Chain Reaction 
(qRT-PCR) was used to quantitate attached viral particle. Primers and probe for 
ML-29/MOPV targeting the L segment: Forward (5′ 
TCCTCAATTAGGCGTGTGAA), Reverse (5′ TACACATCCTTGGGTCCTGA) 
and probe (5′ CCCTGTTCCCTCCAACTTGTTCTTTG). Primer and probe 
targeting LCMV-Armstrong L segment: Forward (5′ CCT TAA AGA GGT GAG 
AGC ATG A), reverse (5′ TTTCATTGATATTCTTGGTTAGGTG) and probe (5′ 
CAGCCACACCTGGATTCTGTAATTGG). Primer and Probe targeting LCMV-WE 
L segment: Forward (5′ CCT GGA CTC TGT AAT TGG CA), Reverse (5′ TTA 
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CAT GCT CAG CAG CAC AG), and probe (5′ TCA CAG TGG ATT TCA CAC 
ACA ACC AGA). 
The attachment of viral particles was assessed quantitatively via the ΔΔCt 
method [60]. Briefly, Ct values corresponding to the viral targets were normalized 
internally via the subtraction of the 18S rRNA levels detected within each sample. 
The resulting ΔCt values of the washed tissue culture cells were then compared 
relative to the bound unwashed Input controls. The resulting ΔΔCt values were 
used to determine the relative quantities of viral nucleic acids in the Bound 
(washed) and Input (unwashed) samples; these values were then plotted, and 
attachment was reported as further calculated via the ratio of Basolateral/Apical 
attachment. 
 
Statistical Analyses.  Statistical significance was analyzed using 3 biological 
replicates per experimental time point, using a Standard Student t-Test. All 
statistical values of p ≤ 0.05 were deemed as statistically significant. 
RESULTS 
 
Identification of appropriate models to study the interaction of mammalian 
arenaviruses with epithelial tissue.  Mammalian arenaviruses have been 
shown to be transmitted to human hosts via inhalation and ingestion of 
contaminated particles [45, 137].  However, cell culture models have not been 
well established to investigate the exact nature of interaction and cellular 
mechanisms during arenaviral infection, as well as a model to investigate 
potential differences in pathogenicity between these viruses.  There have been 
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several studies investigating in vitro models mimicking the bronchial tissue in 
mice [139] as well as a model investigating excretion of these viruses by utilizing 
Madin-Darby canine kidney (MDCK) epithelial cells [138].  To investigate 
potential differences in host-viral interactions between different arenaviruses and 
strains of different pathogenic potential, we sought to explore different cell culture 
models to identify and classify viral-host patterns with cell lines that were capable 
of polarizing, in order to mimic interactions in vivo.  Our goal was to identify one 
or more in vitro models suitable of characterizing differences between our viruses 
of interest.  
 Inhalation of viral particles has been shown to be one way in which 
humans may become infected with mammalian arenaviruses.  In addition to 
natural infection, multiple studies have been conducted to investigate this route 
of infection both in vivo and in vitro [139, 188, 189].  Here, our goal was to utilize 
a human bronchial epithelial (HBE) cell line that closely mimicked an in vivo 
model.  In order to determine whether these cells would be a beneficial model to 
use, viral growth kinetics were assessed by standard plaque assay in both 
polarized and non-polarized HBE cells (Fig. 4).  LCMV-Arm showed poor 
replication in polarized and non-polarized HBE cells, reaching only 1-1.5 logs 
increased replication by 5 days post infection.  The poor replication seen in both 
polarized and non-polarized HBE cells indicates that they are a poor model to 
utilize in determining the role of epithelial barriers during arenaviral infection and 
studies were not further pursued. 






Figure 4 LCMV-Armstrong does not replicate well in polarized human 
bronchial epithelial cells 
Human bronchial epithelial cells were grown on 12-well tissue culture 
plates and infected with LCMV-ARM at an MOI of 0.3PFU/cell.  Supernatants 
were collected every 24 hours for 3 days.  Supernatants were tested using a 
standard plaque assay.   
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Due to arenaviral transmission being involved in aerosolized viral 
particles, most likely due to the excreta of infected rodents hosts, the next 
approach was to investigate a cell line that mimicked the excretion of viral 
particles from the host.  Previous studies have utilized the well-established 
Madin-Darby Canine Kidney (MDCK) epithelial cell line to investigate cellular  
factors associated with LASV entry and release [138].  Here, we investigated 
viral replication to determine if MDCK cells were a suitable model to determine 
viral-host interactions at the epithelial layer, as well as to determine if polarization 
of these cells played any role on replication (Fig. 5).  LCMV-ARM (Fig. 5 A) and 
LCMV-WE (Fig. 2 B) both replicated well in both polarized and non-polarized 
MDCK cells.  LCMV-ARM reached peak titers of around 1X107 in non-polarized 
epithelia, and 1x106 PFU/mL in polarized MDCK cells (Fig. 5 A).     
Interestingly, LCMV-Arm replicated about 2 logs lower in polarized MDCK 
cells as compared to non-polarized MDCK cells.  However, LCMV-WE replicated 
to similar titers, 1x107, in both polarized and non-polarized cells, showing no 
significant difference based on polarity of these cells (Fig. 5 B).  Due to LCMV 
being a close relative, but not entirely indicative of LASV behavior, ML-29 was 
utilized to determine how LASV-GP interacted with MDCK cells (Fig. 5 C).  
Interestingly, ML-29 had very poor replication kinetics in both polarized and non-
polarized MDCK cells, reaching only peak titers of about 5x10^4 in non-polarized 
cells and 5x103 in polarized epithelia.     
 Due to the importance of mimicking LASV infection, we sought to identify 






Figure 5. LCMV-ARM, but not WE is impacted by polarization of MDCK cells 
 MDCK cells were non-polarized (black) or polarized (red) in 96-well plates.  Cells 
were infected at an MOI of 0.3 PFU/cell with LCMV-ARM (A), LCMV-WE (B), or 
ML-29 (C).  Supernatants were collected every 12 hours for 72 hours and tested 
using a standard plaque assay.  Values shown are the means of 3 biological 
replicates with the error bar representing the standard deviation of the mean.  
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Polarized vs. Non-Polarized Kinetics in MDCK Cells 
with 0.3 MOI Infection of LCMV-WE
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Polarized vs. Non-Polarized Kinetics in MDCK Cells 
with 0.3 MOI Infection of ML-29
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Figure 6. MDCK cells are not permissive to LCMV-Armstrong 
 MDCK cells, VeroE6 cells, and Caco-2 cells were infected with an MOI of 0.1 
PFU/mL of LCMV-Armstrong.  Supernatants were collected over a course of 3 
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ML-29.  VeroE6 cells, MDCK cells, and intestinal adenocarcinoma cell 
line, Caco-2, were infected with an MOI of 0.1 PFU/cell of ML-29 (Fig. 6). Here, 
ML-29 shows poor growth kinetics in MDCK cells, reaching peak titers of only 
1X102, barely above the limit of detection for plaque assays.  However, ML-29 
replicates exceedingly well in VeroE6 cells, reaching titers of 1X106.  Additionally, 
replication of ML-29 was successful in Caco-2 cells as well, reaching titers close 
to 1X105.  Due to the replication kinetics of ML-29 in these three cell types, we 
pursued Caco-2 cells as a model for mimicking the interaction of arenaviruses at 
the level of epithelial tissue.  
        
Infection of Polarized Caco-2 Cells with OW Arenaviruses Does Not Affect 
the Monolayer Integrity.  Since the gastrointestinal tract likely plays an essential 
role in the arenavirus rodent-to-human transmission, we used the human  
adenocarcinoma Caco-2 cell line to establish an in vitro model of the intestinal 
epithelia lining of the gut (Figure 7 A) [167]. The formation of a polarized 
monolayer was assessed by TEER and by detection of the tight junction protein 
Zonal-Occludin-3 (ZO-3), a partition marker of the apical and basolateral sides of 
the cells, was readily detected in between sister cells (Figure 7 B). Furthermore, 
polarized Caco-2 were stained with antibody against α-DG, a principal cell 
receptor for OW arenaviruses (Figure 7 B).  
In general, the arenavirus species used in this study are not associated 
with cytopathic effects. Nonetheless, it was essential to the utility of our model to 




Figure 7. Old World (OW) mammarenaviruses do not alter integrity of model 
intestinal epithelia during infection. 
(A) Diagram of Caco-2 cell seeding for apical infection (left) or basolateral 
infection (right) during polarization; (B) After 21-day polarization period, Caco-2 
cells form confluent monolayers with markers of polarization such as apical tight 
junction protein ZO-3 (green), and a-DG (red) on the basolateral side of cells; (C) 
Caco-2 cells were seeded for apical infection (top) or basolateral infection 
(below) and polarized for 21 days. After which the cells were either Mock infected 
with PBS, or lymphocytic choriomeningitis virus (LCMV)-Armstrong, LCMV-WE, 
ML-29, Mopeia (MOPV), or Venezuelan Equine Encephalitis (VEE) virus (vaccine 
strain TC-83) at an MOI of 0.3 PFU/cell. TEER measurements were taken daily 
for 5 days. Values shown are the means of 3 replicates, with the error bar 
representing the standard deviation of the means.  
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line with their non-cytopathic nature, the OW arenaviruses used in this study did 
not negatively affect electric resistance of epithelial monolayers during the 5-day 
observation period, suggesting that integrity of monolayers was preserved during 
infection (Figure 7 C). In contrast, the alphavirus Venezuelan equine encephalitis 
(VEEV) strain TC-83, which is known to be highly cytopathic, readily disrupted 
the integrity of polarized Caco-2 cells. Analysis of the mRNA and protein levels of 
tight junction proteins was tested and no significant change in quantity of tight 
junction proteins was observed in infected cells as compared to mock infected. 
To determine if cellular polarization unexpectedly perturbed the replication 
of OW arenaviruses, polarized and non-polarized Caco-2 cells were infected with 
both strains of LCMV, MOPV, as well as reassortant virus ML-29. The replication 
kinetics were monitored in both polarized and non-polarized cells by plaque  
assay. LCMV-Arm (Figure 8 A) and LCMV-WE (Figure 8 B) exhibited similar 
replication kinetics regardless of the polarization state of the Caco-2 cells. It 
should be noted that at 24 h post infection LCMV-WE did show a slight difference 
in titer between the polarized and non-polarized Caco-2 cells, but these 
differences were not observed in further time points. As such, neither LCMV-Arm, 
nor LCMV-WE, infections were significantly impacted by the polarization of Caco-
2 cells during apical infection (Figure 8). In addition, similar to LCMV, ML-29 was 
not significantly impacted by polarization of these cells (Figure 8 C); however, 
peak viral titers were approximately 2-log lower than those for LCMV or MOPV 







Figure 8 Polarization of Caco-2 cells does not significantly impact OW 
arenaviral replication 
Caco-2 cells were seeded in 96-well plates and polarized for 2 weeks, or plated 
for 3 days (non-polarized) and infected with either LCMV-Arm (A); LCMV-WE (B); 
ML-29 (C); or MOPV (D) at an multiplicity of infection (MOI) of 0.3 PFU/cell. 
Supernatants were collected every 24 h for a 72 h period, and virus production 
was determined via standard plaque assay. Values shown are the means of 3 





has minimal, if any, inadvertent effect on replication kinetics of the OW 
arenaviruses. 
LASV/MOPV Reassortant ML-29 Exhibits Different Viral Entry and Exit 
Patterns Compared to Either LCMV or MOPV.  As described earlier, the  
gastrointestinal tract is one of the major gates of arenavirus entry during rodent-
to-human transmission [17, 45, 137]. During transmission, epithelial barriers may 
affect pathogenicity of the OW arenaviruses [155, 169]. To assess the role of the 
intestinal epithelial barrier during infections of LCMV strains with different 
pathogenic potential for NHPs, the polarized Caco-2 cells were exposed either 
apically or basolaterally to the aforementioned OW arenaviruses. To verify the 
integrity of the polarized monolayer during the experiment, TEER was measured 
regularly, and the apical and basolateral supernatants were collected every 24 h 
for a period of 5 days. 
Apical exposure of polarized Caco-2 cells to both strains of LCMV resulted 
in robust infection and virus release from primarily the apical cell surface. 
Nonetheless, basolateral release of infectious virus particles was observed at 
later times post infection. Therefore, while infectious particles were released from 
both surfaces, the release was more efficient from the apical surface, with a ~2-
log difference between the two supernatants (Figure 9 A). In contrast, when 
polarized Caco-2 cells were exposed to LCMV-Arm and LCMV-WE via the 
basolateral side, infection resulted in roughly the equivalent release of infectious 
particles from both cell surfaces (Figure 9 B). 




Figure 9 LCMV-Armstrong and LCMV-WE show similar patterns of entry 
and release in polarized Caco-2 cells regardless of pathogenic differences. 
Caco-2 cells were polarized on 0.4 µm Transwell inserts in apical or basolateral 
orientation, for 21 days. After integrity of the monolayer was verified using TEER, 
the cells were infected with either LCMV-Arm, LCMV-WE, at an MOI of 0.3 
PFU/cell on either the apical (A); or basolateral (B) side of polarized Caco-2 cells. 
Supernatants were collected from both the insert, and well of the Transwells, to 
determine viral release from the apical or basolateral surfaces independent from 
one another. Viral titer was measured using standard plaque assay. Release 
from the Apical surface (black) and the Basolateral surface (red) is plotted with 
respect to time, with initial viral load subtracted. Values shown are the means of 
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3 biological replicates with the error bar representing the standard deviation of 
the mean. If viral plaque forming units (PFUs) were not observed, data received 
a place-holder value to signify samples were tested, but no data (ND) was 
collected. # indicates that one or more biological replicates was below limit of 





Figure 10. ML-29 replication in polarized Caco-2 cells differ from the 
replication patterns of LCMV. 
Caco-2 cells were polarized on 0.4 µm Transwell inserts as stated for Figure 9. 
Cells were then infected on the apical (A) or the basolateral (B) surface of the 
cells with an MOI of 0.3 PFU/cell of reassortant vaccine candidate ML-29. 
Supernatants were collected from transwells and inserts to determine viral 
release from the apical or basolateral surfaces independent of one another, on 
every day for 5 days. Release from the Apical surface (black) and the Basolateral 
surface (red) is plotted with respect to time, with initial viral load subtracted. 
Values shown are the means of 3 biological replicates with the error bar 
representing the standard deviation of the mean. If viral PFUs were not 
observed, data received a place-holder value to signify samples were tested, but 
no data (ND) was collected. # indicates that one or more biological replicates 




In addition to the two strains of LCMV described above, the patterns of viral entry 
and release of ML-29 was assessed in the polarized Caco-2 model. As shown in 
(Figure 10 A) Caco-2 cells apically infected with ML-29 failed to produce 
detectable virus particles from the basolateral surface, despite the apparent 
release of infectious viral particles from the apical side. Comparative  
analysis indicates a 2-3-fold difference between viral apical and basolateral 
release during apical ML-29 infections of polarized Caco-2 cells. Curiously, 
infection of the polarized Caco-2 cells via the basolateral side resulted in only 
apical release (Figure 10 B). Notably, the release of infectious ML-29 progeny 
were temporally delayed during basolateral infections, and resulted in the 
formation of low viral titers.    
Parallel analysis of MOPV infection reveals a pattern of viral release 
similar to that observed for LCMV. As shown in (Figure 11 A), the apical infection 
of polarized Caco-2 cells primarily resulted in the release of infectious viral 
particles from the apical surface; however, basolateral release was observed. 
Similar to LCMV, and different from ML-29, basolateral infection of polarized 
Caco-2 cells resulted in the more-or-less equivalent release of viral progeny 
apically and basolaterally. A summary of entry and exit kinetics can be seen in 
Figure 12. 
 
Attachment and Binding of OW Arenaviruses to Polarized Caco-2 Cells.   
To assess if the aforementioned OW arenaviruses differed in their 




Figure 11. Mopeia virus replication in polarized Caco-2 cells follows a 
similar pattern as LCMV replication. 
Caco-2 cells were polarized on 0.4 µm Transwell inserts in apical or basolateral 
orientation, for 21 days. After integrity of the monolayer was verified using TEER, 
the cells were infected with MOPV, at an MOI of 0.3 PFU/cell on either the apical 
(A) or basolateral (B) side of polarized Caco-2 cells. Supernatants were collected 
from both the insert, and well of the Transwells, to determine viral release from 
the apical or basolateral surfaces independent from one another. Viral titer was 
measured using standard plaque assay. Release from the Apical surface (black) 
and the Basolateral surface (red) is plotted with respect to time, with initial viral 
load subtracted. Values shown are the means of 3 biological replicates with the 
error bar representing the standard deviation of the mean. If viral PFUs were not 
observed, data received a place-holder value to signify samples were tested, but 
no data (ND) was collected. # indicates that one or more biological replicates 





Figure 12. Summary of entry and exit patterns of OW arenaviruses in 
polarized Caco-2 cells 
LCMV-ARM, LCMV-WE, and MOPV entered (Blue arrow) on the apical surface 
of Caco-2 cells and released primarily to the apical surface (Black arrow) with 
slight release from the basolateral surface (Red arrow). When exposed to the 
basolateral surface, LCMV and MOPV released from both the apical (Black 
arrow) and basolateral (Red arrow) surfaces of the cells.  ML-29, when exposed 
to either the apical or basolateral surface of polarized Caco-2 cells released from 




at an equal MOI (0.3 PFU/Cell), via the apical or basolateral surfaces. Cells were 
incubated at 4 °C for 1 h to allow virus to attach, but not penetrate the host cell. 
To determine the relative attachment rates of the viral particles, the total RNA 
was extracted from unwashed and washed tissue culture cells of at least three 
biological replicates derived from at least two independently generated viral 
stocks. The relative abundance of viral RNA was detected by qRT-PCR using 
virus-specific primers to determine the percent of input of virus particles that 
bound to the polarized Caco-2 cells. 
Analysis of LCMV attachment indicated that for both LCMV-ARM and 
LCMV-WE ~5% of the input virus adsorbed to the polarized Caco-2 cells (Figure 
13 A, B). Comparisons of apical- and basolateral-bound viral levels indicated that 
LCMV-ARM exhibited preferential binding to the basolateral surface of the 
polarized Caco-2 cells (Figure 13 A). LCMV-WE, in contrast, did not exhibit 
preferential binding to either surface (Figure 13 B). Collectively, these data 
indicate a potential difference between the two LCMV strains in regards to cell 
attachment. Assessment of ML-29 binding indicated a strong attachment 
preference to the apical surface of the cells. As shown in (Figure 13 C), 
approximately 4-fold more virus attached to the apical surface relative to the 
basolateral surface of polarized Caco-2 cells. These data are in apparent 
congruence with the observations reported in Figure 4, where basolateral 
infection were less efficient as compared to parallel apical infections. Quantitative 




Figure 13 Attachment of ML-29 on the basolateral surface of polarized 
Caco-2 cells is significantly lower than apical attachment 
Caco-2 cells were polarized on 0.4 µm Transwell inserts for 21 days in either 
apical or basolateral orientation. Cells were then infected with an MOI of 0.3 
PFU/cell of LCMV-Arm (A); LCMV-WE (B); ML-29 (C); or MOPV (D) at 4 °C for 1 
h to allow virus to attach to the epithelial cell surfaces, but not enter the cells. 
After 1 h, cells were either unwashed (input) or washed and cellular RNA and 
supernatants were collected for quantitative real-time polymerase chain reaction 
analysis. Ratio of basolateral to apical attachment was taken by dividing 
basolateral ΔΔCT values of washed cells by the apical ΔΔCT values of washed 





Specifically, as shown in (Figure 13 D) the attachment of MOPV virus was 
equivalent amongst the apical and basolateral surfaces. 
Since we cannot directly compare the absolute levels of attachment for 
each surface between the individual virus species, we must compare the ratios of 
apically and basolaterally bound viruses to identify statistical differences between 
the four OW arenaviruses used in this study. Overall, these comparisons indicate 
that LCMV-ARM and ML-29 differ from the other viruses, and each other, in  
regards to their binding proclivities. LCMV-Arm has a ratio of apical and 
basolateral attachment of approximately 1.5, indicating that attachment has a 
slight preference to the basolateral surface of the polarized Caco-2 cells (Figure 
13 E). The ratio of basolateral and apical attachment of LCMV-WE and MOPV of 
approximately 1, indicates that LCMV-WE and MOPV attachment is more or less 
equivalent in its binding to the apical and the basolateral surfaces of Caco-2 cells 
(Figure 13 E). While LCMV-ARM is unique in its binding preference as compared 
to the other viruses, this indicates that LCMV-ARM, LCMV-WE, and MOPV all 
attach to some degree on the apical and basolateral surface of the cells. 
However, the ratio of basolateral and apical attachment of ML-29 indicates that 
there is a large difference between viral attachment between the two surfaces, 
with a significant preference for the apical side of the polarized Caco-2 cells 
(Figure 13 E). ML-29’s preference for the apical surface with comparatively little 
to no binding on the basolateral surface, is significantly different than that of 
LCMV and MOPV. Collectively, these data indicate that LASV-GP has a 
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significantly different binding efficacy to the basolateral side of Caco-2 




Epidemiological observations in West Africa indicate that the ingestion of 
food contaminated with excreta of infected M. natalensis is one of the natural 
mechanisms of LASV transmission to humans [17]. Up to 45% of individuals 
living in some LASV endemic regions in Western Africa can be seropositive to 
the virus; and if re-infection occurs, seropositive individuals can protect 
themselves from disease onset. However, seronegative individuals may also be 
protected from disease, due to protection associated with cell-mediated immunity 
[147]. This implies high prevalence into endemic populations; however, the 
precise mechanisms behind this phenomenon are unknown. In NHP studies of 
arenavirus disease, LCMV-WE causes LF-like disease via intravenous (i.v.)-
infection, whereas LCMV-ARM shows chronic infection, with no disease onset 
[155]. Furthermore, high titer i.v. infections of NHPs with LCMV-WE resulted in 
uniform mortality [155]. Nevertheless, i.g. infection with identical titers showed a 
variable outcome, ranging from no signs and symptoms to fatal, LF-like disease 
with elevated aspartate and alanine aminotransferases (ALT/AST) levels [155, 
182]. Elevated ALT and AST levels are symptomatic of hepatic tissue damage, 
and highly elevated levels are associated with lethal LF disease of humans in 
endemic regions [96]. In addition, some of the surviving animals survived i.v. 
challenge, indicating that LCMV infection did occur as a competent humoral 
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response was induced [182]. Due to probable infection via the ingestion of 
contaminated food stuffs, and the variable outcomes of intragastric infection in 
vivo, we sought to investigate whether or not the patterns of entry and exit when 
polarized Caco-2 cells were exposed to OW mammarenaviruses apically 
(intragastric route) or basolaterally (intravenous route). Due to the unsuccessful 
infections of LCMV and ML-29 in HBE and MDCK cells, we did not further pursue 
these cell lines, resulting in our focused studies of the interaction of Caco-2 cells 
and OW mammalian arenaviruses.   
As previously described, LASV and LCMV entry into MDCK cells and HBE 
cells occurs primarily via the basolateral side, and release of viral particles was 
predominantly from the basolateral surface. These in vivo and in vitro studies led 
us to investigate the role of the intestinal epithelial barrier during OW arenavirus 
infection. In this study, we characterized an in vitro model of intragastric infection 
to assess the interaction of OW mammarenaviruses with the intestinal epithelia in 
an amenable tissue culture system. This system utilized polarized Caco-2 cells 
grown on transwells, which is a well-established cell type and cell culture system 
used for in vitro studies of the intestinal barrier [173, 187]. This system enables 
the independent examination of the role of the apical and basolateral epithelia 
surfaces during viral infection. Therefore, this model recapitulates the infection of 
intestinal epithelial cells from the luminal and laminal sides of the epithelial 
monolayer via the apical and basolateral surfaces, respectively. 
Using this model system, we evaluated infections of LCMV strains of 
different pathogenic potentials. We also used a MOPV/LASV reassortant, ML-29, 
61 
 
a validated BSL2 surrogate model that is capable of mimicking the interaction of 
LASV with susceptible cells. ML-29 expresses GP1 attachment glycoprotein 
identical to LASV GP1, and MOPV, attenuated genetic relative of LASV. Since 
ML-29 is a reassortant virus of LASV/MOPV, it represents a better system in 
which arenaviral biology can be determined compared to VSV or retrovirus-
based pseudotypes expressing LASV GPC as the viruses contain genuine 
arenaviral replication machinery. 
From the in vivo studies in NHPs, it was expected for virus to release 
infectious particles from primarily the apical side, since viral particles were not 
detected in any tissues after intragastric infection with LCMV [155]. However, 
when exposed on the apical side of epithelial cells, LCMV and MOPV primarily 
released on the apical side of the cells, but release basolaterally was observed. 
This observation indicates that the epithelial barrier is not the sole determinant of 
viral dissemination. Interesting to note as well, was that patterns of replication 
were similar regardless of the in vivo pathogenicity of the LCMV strains. 
Therefore, the infectious capacity of these viruses in vitro, in regards to Caco-2 
cells, does not correlate with pathogenic properties for LCMV. Therefore, further 
investigation as to the driving forces of pathogenic differences needs to be 
investigated. However, in contrast to LCMV, the ML-29 expressing LASV GP1, 
predominantly released viral particles apically regardless of the route of entry. 
Furthermore, these results demonstrate that MOPV entry-release pattern in 
polarized Caco-2 cells resembled those in cells infected with LCMV, and was 
clearly different from ML29-driving entry-release. Due to ML-29 replication 
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patterns being different than that of MOPV replication, these patterns of entry 
and release are not due to MOPV replication machinery, and may be attributed to 
the gene products of the S segment of LASV, namely the glycoproteins and 
nucleoprotein. This poor replication and egress to the basolateral sides of the 
cells is an interesting observation. While ML-29 is not WT-LASV, using WT-LASV 
in similar studies could lead to an explanation as to why almost half of the 
population of endemic regions are seropositive for LASV, but never 
demonstrated clinical signs of disseminated illness. In addition, the data 
presented here indicates that the capacity to infect via the apical surface of 
intestinal epithelial cells is not a primary determinant of arenavirus pathogenesis. 
ML-29 was developed as a potential vaccine for the prevention of LASV 
infection. As seen here, ML-29 had a much greater binding rate leading to 
successful infection when exposed to the apical side of polarized intestinal 
epithelia. If after successful attachment following the ingestion of viral particles 
fails to release viral particles basolaterally, this may be an exceptionally potent 
tool for the development of successful immunity against LASV in at-risk 
populations. These results provide additional evidence for attenuation of ML-29 
as a vaccine strain for LASV. From these in vitro studies, and the dire need for a 
LASV vaccine, studies examining the importance of the route of exposure to ML-
29 in an in vivo model should be investigated as a potential therapy to LASV 
infection and prevention. 
A recent publication from Oppliger et al. identified entry of a recombinant 
LCMV expressing LASV-GP (rLCMV-LASVGP) in polarized Caco-2 cells [190]. 
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Here, rLCMV-LASGP showed preferential entry into polarized Caco-2 cells on 
the basolateral surface of these cells. Opposingly, we identified via qRT-PCR 
that viral attachment of ML-29, a reassortant containing the GP1 of LASV, 
preferred the apical surface of polarized Caco-2 cells. Interestingly, we did see 
LCMV preferentially attaching to the basolateral surface of polarized cells, as 
seen with rLCMV-LASVGP. However, the rLCMV-LASGP studies did not 
elucidate the viral release patterns of rLCMV-LASVGP in polarized Caco-2 cells, 
nor the initial attachment of viruses to these cell surfaces. Furthermore, due to 
ML-29’s genetic differences to the LCMV-backbone of rLCMV-LASVGP, our 
results and those of Oppliger et al. cannot be directly compared. Taken together, 
our observations, are a useful addition to the field to further investigate precise 
differences between rLCMV-LASVGP and ML-29 in order to evaluate genetic 
variations of these viruses to more accurately identify potential targets for LASV 
therapeutics and further understand the replication cycle of LASV. 
Some questions still lie as to the reason that ML-29 bound so inefficiently 
on the basolateral side of Caco-2 cells. Although primary receptor (α-DG) is 
located on the basolateral surface of the polarized Caco-2 cells, this data, along 
with the data of others, provides further support that LASV has complex receptor 
usage. Additional receptors for LASV should be investigated in the Caco-2 
system, including Axl, DC-SIGN and Tyro3. Along with additional receptors and 
their role in our system, the interaction with α-DG should also be investigated. An 
excellent review by Torriani et al. describes a number of studies that explain the 
complex viral-receptor interaction of LASV [191]. Although fully functional α-DG 
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was detected basolaterally in polarized Caco-2 cells, ML-29’s binding efficiency 
was low. This may be due to a multitude of reasons including the use of other 
cellular factors and receptors used in addition to α-DG to attach to these 
polarized cells, or differences and mutations that ML-29 may contain as 
compared to WT LASV, especially those present in the GP2 protein. Previous 
research has identified that LASV infection was dependent upon sodium 
hydrogen exchangers (NHEs), as well as actin cytoskeleton to have successful 
viral entry into host cells [40]. Investigations into these factors during infection of 
polarized Caco-2 cells should be analyzed to determine a reason for inefficient 
and poor binding of ML-29 on the basolateral side of these cells. Although ML-29 
contains the S segment of LASV, the L segment of MOPV may interfere with 
complete and successful viral replication that WT LASV may have, 
comparatively. However, we believe the latter to be a minimal or insignificant 
inhibition of viral attachment and replication due to MOPV replicating similarly to 
LCMV in polarized Caco-2 cells when exposed to the basolateral side of the 
cells, as compared to little or no viral replication by ML-29 after basolateral 
exposure. Thus, investigation into precisely how WT LASV attaches, enters, and 




To conclude, our data above demonstrates that the polarized Caco-2 
system is a viable model to investigate the interaction of intestinal epithelial cells 
during viral infection with OW mammarenaviruses. These polarized epithelia 
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closely mimic intestinal epithelial of human hosts and allow further investigation 
of mammarenaviral infection at the epithelial barrier. These data with LCMV 
show that intestinal epithelial cells may not be the sole determinant of viral 
pathogenesis and dissemination. Furthermore, differences between prototypic 
arenavirus LCMV and the surrogate model of LASV interaction, ML-29, were 
observed in both attachment efficiency and viral entry and egress from polarized 
intestinal epithelia. These results may potentially explain the high penetrance 
without disease observed for LASV. In addition, ML-29’s diminished binding 
efficiency to the basolateral side of polarized Caco-2 cells supports the 
expanding complexity of arenavirus receptor interactions. Collectively, these 
studies show that arenaviral infection of polarized cells is not only viral specific, 
but ultimately may be tissue and host-specific as well; and that arenavirus 
infection and pathogenesis may be dependent on asymmetric distribution of viral 
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Lymphocytic choriomeningitis virus (LCMV), prototype of rodent-borne 
arenaviruses, and Lassa virus (LASV), causative agent of the most prevalent 
hemorrhagic fever in West Africa Lassa Fever (LF), share many genetic and 
biological features.  Both species comprise of a collection of highly diverse, 
genetically and biologically, virus isolates from rodent hosts and humans. 
Pantropic LCMV-WE causes fatal LF-like hepatitis in non-human primates 
(NHPs); while heavily adapted in mice, LCMV-ARM strain, is deeply attenuated 
in NHPs and can protect animals against fatal WE challenge. Similarly, Mopeia 
virus (MOPV), a genetic relative of LASV, causes asymptomatic infection in 
NHPs, and protects them against fatal LF. Previously we demonstrated that non-
pathogenic MOPV and LCMV-ARM (but not LASV and LCMV-WE) induced 
robust Toll-like receptor 2 (TLR2)/Mal (MyD88 adaptor-like)-dependent and NF-
κB-mediated cytokine responses. These responses correlated with virus 
replication. In this study, we demonstrate that LCMV strains with different 
pathogenic potential had distinct intracellular trafficking patterns in macrophages. 
After internalization, LCMV-ARM strongly interacted with TLR-2, and markers of 
early and late endosomes where nucleic acid-sensing TLR-7 and-9 are located. 
In contrast, LCMV-WE bypassed the early endosomal compartment, and had 
less extensive interaction with late endosomes/lysosomes markers as assessed 
by co-staining experiments by confocal microscopy. LCMV-WE NP antigen was 
strongly co-localized with IRAK-1 and can affect NF-κB-mediated signaling. 
Internalization of LCMV-WE in Vero and Caco-2 cells was more sensitive to 
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depletion of membrane cholesterol and disruption of microtubules in polarized 
epithelial cells than LCMV-ARM infection. These findings suggest that non-
pathogenic LCMV-ARM infection is more efficient in terms of activation of TLRs- 




 Lymphocytic choriomeningitis virus (LCMV) is a prototypic virus of the 
Arenaviridae family, which was dramatically reshaped after the discovery of 
snake-borne viruses.  Until recently, all arenaviruses have been placed into one 
genus, Arenavirus, and were divided into two groups based on geographical 
locations and serological relationships; Old World (OW) arenaviruses (or LCMV-
LASV sero-complex) and New World (NW) arenaviruses (or Tacaribe, TCRV, 
sero-complex). Lassa virus (LASV) is the most prevalent human pathogen 
among OW arenaviruses, infecting hundreds of thousands of individuals annually 
in West Africa, some of them resulting in fatal Lassa fever (LF). Junin virus 
(JUNV), causative agent of Argentine hemorrhagic fever (AHF), is the most 
significant human pathogen among NW arenaviruses. All arenaviruses share 
common features as enveloped RNA viruses, with a two-segmented, single-
stranded, ambisense genome. The large (L) RNA, encodes L protein (RNA 
polymerase) and matrix Z protein. The small (S) RNA encodes the most 
abundant protein, nucleocapsid protein (NP), which is tightly associated with 
RNA in virions and in infected cells.  Additionally, S encodes the enveloped 
glycoprotein precursor (GPC) protein, which is processed in infected cells into 
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stable signal protein (SSP), GP1 (attachment), and GP2 (fusion) glycoproteins 
[192]. Intergenic region with extensive secondary structure separate the genes in 
both RNA segments, and is required for transcription and replication. 
In 2014, rodent-borne arenaviruses, comprising a single Arenavirus 
genus, were placed in the renamed genus Mammarenavirus. A new genus, 
Reptarenavirus, was established for newly discovered arenavirus-like viruses 
isolated from alethinophidian snakes [3]. Recently, eight novel species were 
included in the genus Mammarenavirus for murid viruses isolated in Africa and 
Asia. The genus Hartmanivirus was created to accommodate a novel arenavirus 
isolated from a captive snake in Finland [3]. In addition, the Arenaviridae family 
was placed into the newly established order Bunyavirales for related viruses with 
single-stranded negative-sense (or ambisense) RNA genomes [193].     
 LCMV and LASV share biological features including their interaction with 
major cellular receptor α-dystroglycan (α-DG) [10], and pathogenicity in guinea 
pigs and non-human primates (NHPs) [194, 195]. Both species, Lymphocytic 
choriomeningitis mammarenavirus and Lassa mammarenavirus, comprise a 
collection of highly diverse (genetically and biologically) virus isolates from rodent 
and humans, phylogenetically placed into 4-6 lineages [196-201]. The unbiased 
pairwise sequence comparison (PASC) analysis split LASV and LCMV strains 
into 6 and 5 distinct species, respectively. A conservative PASC cut-off (>80% 
and >76% nucleotide sequence identity in the S and L segments, respectively, to 
belong to the same species) was proposed to leave the current taxonomy of 
mammalian arenaviruses intact [3].   
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LASV causes infection with broad clinical manifestations, from sub-clinical 
or flu-like disease, to fatal LF disease and is found in endemic areas of West 
Africa.  In contrast, LCMV is widely spread across continents and causes 
asymptomatic or mild infections, which rarely progress to aseptic meningitis or 
meningo-encephalitis [128, 202]. However, during the third trimester of 
pregnancy, a relatively immune-suppressed state, both viruses, LASV and 
LCMV, can cause infection with disastrous consequences for the fetus [128, 
203]. Furthermore, in immunocompromised recipients that received LCMV-
infected organs, the virus can cause fatal LF-like infection [113, 114].   
 LASV and genetically related non-pathogenic Mopeia virus (MOPV), are 
hosted by the same rodent species, Mastomys natalensis, and can produce 
interspecies reassortants in vitro after co-infection cells with both viruses. One of 
these reassortants, clone ML29, carrying the L RNA from MOPV and S RNA 
from LASV, is a promising LF vaccine candidate [85]. Similarly, pantropic LCMV-
WE strain, causing LF-like fatal hepatitis in non-human primates (NHPs) [153, 
156], can produce reassortants in vitro with neurotropic strain LCMV-ARM [204], 
which is highly adapted in murine cells and fully attenuated in NHPs. For both 
types of reassortants, interspecies MOPV/LASV and intertypic WE/ARM, the 
pathogenic potential for humans and NHPs was linked to the L RNA encoding 
RNA polymerase [204, 205]. Furthermore, LCMV-WE is highly pathogenic for 
outbred guinea pigs (LD50 <~1 PFU), while mouse-adapted LCMV-ARM is fully 
attenuated in these animals (>6 log10 PFU failed to kill) [194]. 
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 The immunosuppressive phenotype of LASV infection contributes to fatal 
outcomes in progressed cases of human LF disease, and in experimentally 
infected NHPs [206, 207]. We previously documented that LASV and LCMV-WE, 
but not MOPV and LCMV-ARM, down-regulated innate pro-inflammatory 
responses in vitro and in vivo [87, 102, 153, 156, 167]. Particularly, cells infected 
with LASV and LCMV-WE, inhibited Toll-like receptor 2 (TLR2)/Mal (MyD88 
adaptor-like)-dependent cytokines [167]. In contrast, MOPV and LCMV-ARM, 
induced robust NF-κB-mediated, Mal-dependent pro-inflammatory responses in 
human epithelial cells, monocytes, and in murine bone marrow-derived 
macrophages [167]. These responses were TLR2/Mal-dependent, required virus 
replication, and were enhanced by CD14 [167].  Virus internalization and virus 
replication was required for activation of TLR2/Mal-dependent signaling [167]. 
Strong activation of monocyte-macrophages seems to be a general 
feature of non-pathogenic mammalian arenaviruses [102, 158-162].  In addition 
to LCMV-ARM and MOPV,  TCRV, but not pathogenic JUNV, induced cytokines 
release from these cells [158]. With these similarities, TLR2/Mal/MyD88-
dependent signaling has some differences between the OW and NW mammalian 
arenaviruses. In the case of Candid 1 (attenuated JUNV vaccine), engagement 
of TLR2/6 heterodimers on the cell surface, with viral glycoprotein, was sufficient 
to trigger cytokine response via RIG-I/MDA5, NF-κB, and Erk1/2 pathways and 
did not require internalization and viral replication [55]. 
In the virus overlay protein-binding assay (VOPRA), LASV and LCMV-WE 
bound to its major cellular receptor, α-DG, with higher affinity and efficiency than 
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non-pathogenic Mobala virus (MOBV) (which is genetically closely related to 
MOPV), and LCMV-ARM [10, 13]. However, while both LCMV strains, WE and 
ARM, replicated with the similar kinetics in human monocyte derived cells, only 
the replication of LCMV-ARM resulted in robust TLR2/Mal-dependent pro-
inflammatory cytokine responses [167]. Interestingly, attachment efficacy of 
infectious particles of both strains of LCMV, as well as patterns of entry and exit, 
were similar in polarized epithelial Caco-2 cells [208].  In line with these 
observations, LCMV strains with high and low bidding affinity to α-DG, infect 
BHK-21 cells with equal efficiency [209]. Additional entry factors recently 
discovered in vitro for LASV and LCMV (DC-SIGN, LSECtin, Axl, and Tyro3) 
seem play a role in virus entry [30, 31, 210, 211]. At least one of these factors, 
Axl, was strongly upregulated in maturated hepatocytes lacking functional α-DG 
(O-mannosyl glycosylated) in mice infected with LCMV-WE (but not in LCMV-
ARM) [212].  
Taken together, these facts indicate that the engagement of receptors, 
and/or attachment cofactors, on the cell surface by viral glycoproteins cannot be 
solely responsible for trigger (or suppression) of virus-induced pro-inflammatory 
responses. All consequential steps (internalization, intracellular trafficking and 
cross talk with cellular factors, fusion in late endosomes/lysosomes, and 
triggering of RIG-I-dependent signaling), can differently contribute to innate and 
adaptive immune responses driving pathogenicity. In this study we have 
compared intracellular trafficking of LCMV-WE and LCMV-ARM using co-staining 
with markers of early and late endosomal compartments and treatment of cells 
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with drugs targeting different steps of virus replication.  In LCMV-ARM-infected 
macrophages viral NP antigen was extensively co-localized with TLR-2 in early 
endosomes, and was co-stained with markers of late endosomes where nucleic 
acid sensing TLR-7 and TLR-9 are located. In contrast, LCMV-WE bypassed the 
early endosomal compartment, and had less extensive interaction with late 
endosomes/lysosomes markers as assessed by co-staining experiments and by 
confocal microscopy. LCMV-WE infection of murine macrophages resulted in 
strong co-localization of viral NP with IRAK-1 in line with of NF-κB suppression in 
infected cells [167], 
Furthermore, LCMV-ARM infection was more sensitive to pH changes of 
late endosome, tested with bafilomycin A1, in comparison to LCMV-WE. These 
findings are in line with previous observations, documenting high sensitivity of 
MOPV to NH4Cl in comparison to LASV [213]. Taken together, these data 
suggest that fusion events in late endosomes drives viral RNA release kinetics 
resulting in the differential triggering of the cellular RIG-I machinery and innate 
responses.   
MATERIALS AND METHODS 
 
Cells and Viruses. Vero E6 (C1008) , Caco-2 (HTB-37), and RAW264.7 (TIB-
71™) cells were purchased from American Type Culture Collection (ATCC). 
Caco-2 cells were grown and polarized as previously described [208].  Cells were 
infected with LCMV-Armstrong (strain 53b) or LCMV-WE (strain 54).  All viral 
stocks were generated using low multiplicity of infection (MOI) and stocks were 
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generated ranging from 1 x 107 to 1 x 108 PFU/mL and stored at -80°C until 
further use [88].  Infectious virus titration was performed in Vero E6 cells using a 
standard plaque assay with minor modifications that have been previously 
described [167, 208].  Briefly, VeroE6 cells were plated in 12 well plates.  When 
Vero Cells reached 80-90% confluent, viral samples were serially diluted and 
used to infect.  Infection was carried out for 1 hour in 37°C.  Cells were then 
washed with PBS, and a semi-solid overlay containing 1X MEM, 5% FBS, and 
0.5% Avicel (FMC BioPolymer, Philadelphia, PA, USA) was added to the cells.  
Cells were incubated for 5 days in a humidified chamber at 37°C and 5% CO2.  
After a 5-day incubation, the semi-solid overlay was removed, cells were washed 
with PBS, and fixed with 4% paraformaldehyde (PFA).  After a 15-minute fixation, 
cells were stained with a 1% Crystal Violet solution to identify virus-infected foci, 
with a limit of detection of approximately 80 PFU/mL.    
TLR-2 silencing.  RAW264.7 cells were pretreated with TLR2 Silencer® select 
pre-designed siRNA (Ambion, P/N 4390771). Transfection was performed with 
Lipofectamine (Lipofectamine RNAi Max Reagent, Invitrogen) for 48 hours. 
Control cells were transfected with Silencer® Negative Control siRNA (Ambion). 
Transfection of mock-infected cells with TLR2 siRNA resulted in moderate 
suppression of TLR-2 mRNA (46%), and TLR-2 expression on the cell surface as 
assessed by staining transfected cells with anti-TLR-2 antibody and flow-
cytometry (36.5%). Transfected cells were infected with LCMV stains at MOI > 1 
and incubated for 24 hrs. The mRNA levels of IL-6 were determined by real-time 
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PCR using commercial primers/probe as previously described [167]. Expression 
of IL-6 at protein level was analyzed by ELISA kit (eBiosciencecat, P/N 88-7064). 
Immunofluorescence co-staining, confocal microscopy. RAW264.7 cells 
were grown in chamber slides (Lab-Tek), and infected with LCMV strains at MOI 
>1. After virus internalization, intracellular trafficking of LCMV infection was 
monitored in co-staining experiments using monoclonal antibody against a 
conserved NP epitope (M104, Abcam, 1:100 dilution), TLR-2 (monoclonal 
CD282, eBioscience, 1:200), EEA1 (monoclonal F.43.1, Thermo scientific, 
1:100), RAB-7 (rabbit monoclonal EPR7589, Abcam, 1:100), LAMP1 (polyclone 
C-20, Santa Cruz, 1:100), IRAK-1 (D51G7, Cell Signaling, 1:250). Infected cells 
were incubated in CO2 incubator for 0.5 – 2 hrs (see legends to Fig. 15,16,18, 
and 19 for more details), fixed with PFA and permeabilized. After blocking of non-
specific binding with 1% BSA, cells were co-stained with primary antibodies (2-4 
hrs, RT) and treated with the secondary IgG-TR or IgG-FITC antibodies (anti-
mouse or anti-rabbit, 1:200 dilution for 30 min at RT). To stain nuclei, DAPI Flu –
G (Southern Biotech) was used mount coverslips on slides. Co-staining patterns 
were examined by confocal microscopy (LSM 710, Zeiss) as previously 
described, and co-localized staining was quantitated (see Supplemental 
Materials).  
Confocal Microscopy. The analysis was performed as recently described for 
LCMV infected cells using ZEN software [214] with slight modifications. Up-to 
eight LCMV NP-positive (green cells) cells were marked and compared pixel by 
pixel with intensity signals from each channel. Background for green and red 
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channels was determined based on mock-infected cells staining. Total (green-
and red-positive) signals were divided by the sum of green positive pixels and 
expressed as co-localization efficiency, (%). The calculation was repeated for 
individual cells 
Treatment with Chemical Inhibitors.  Treatment with methyl-β-cyclodextrin 
(Mβ-CD) was modified from previous work [36, 215, 216].  Briefly, VeroE6 or 
Caco-2 cells were seeded in 12-well tissue culture plates.  Cells were then pre-
treated in the presence, or absence (control cells), of 5mM Mβ-CD (Sigma-
Aldrich, St. Louis, MO, USA) for 1 hr at 37°C.  Cells were infected with an MOI of 
0.3 PFU/cell, and incubated for 24 hrs in the presence of Mβ-CD. Percent 
replication after inhibition was determined by normalizing viral titer after treatment 
with the drug, compared to infections titer without membrane cholesterol 
depletion.  Treatment with nocodazole was slightly modified from previous 
studies [35, 43, 217].  Briefly, VeroE6 or Caco-2 cells were pre-treated with 10μM 
nocodazole for 1 hr at 37°C.  Cells were then washed 2 times with cold PBS, 
infected with a MOI of 0.3 PFU/cell for 1 hr and then incubated in the presence of 
nocodazole for 24 hrs at 37°C.  Bafilomycin treatment was also slightly modified 
[28, 218].  VeroE6 cells were pre-treated with bafilomycin A1 (Sigma-Aldrich, St. 
Louise, MO, USA) with concentrations ranging from 10 to 200 nM.  Cells were 
infected at an MOI of 1.0 PFU/cell, at 4°C for 1 hr, in the presence of bafilomycin 
and incubated with the drug for 24 hrs at 37°C.  Supernatants were collected for 
standard plaque assays and cells were collected in RNA-STAT-60 (Tel-Test 
Inc.,) further RNA isolation according to the manufacturer’s instructions.  
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Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was used to 
quantitate viral RNA in treated and untreated cells using LCMV strain-specific 
primers/probe as previously described [208].   
Statistical Analyses.  Statistical significance was analyzed using 3 biological 
replicates per experimental time point and treatment concentration, using a 




TLR-2 knockdown results in down-regulation of IL-6 expression in LCMV-
ARM-infected murine macrophages. In previous experiments, LCMV-ARM 
(but not LCMV-WE) infection of cells human derived from murine or human 
monocytes/macrophages induced strong production of IL-6 [167]. This induction 
was TLR2/Mal-dependent since murine macrophages generated from TLR-2 or 
Mal knockout mice failed to induce cytokine responses.  In current experiments, 
we have used the transformed murine macrophage cell line RAW264.7. To prove 
TLR-2 dependency of IL-6 stimulation in LCMV-ARM-infected cells, RAW264.7 
cells were transfected with pre-designed TLR-2 siRNAs, and infected with LCMV 
strains at MOI > 1 PFU/cell. Induction of IL-6 was assessed at mRNA and protein 
levels, by RT/PCR and ELISA, respectively.   
 Consistent with previous study, both LCMV virus strains had similar 
replication kinetics in RAW cells [167]. However, only LCMV-ARM infection 





Figure 14. TLR2 siRNA transfection down regulates IL-6 in LCMV-ARM-
infected murine macrophages. 
Murine-specific TLR-2 siRNA, and Negative Control siRNAs (Ambion) were 
transfected into RAW264.7 cells using Lipofectamine (Lipofectamine RNAi Max 
Reagent, Invitrogen) for 48 hours. Transfected cells were infected either with 
LCMV-ARM or with LCMV-WE at MOI >1 PFU/cell incubated for 24 hours. A. IL-
6 mRNA expression was determined by real-time PCR. B.  Protein expression of 
IL-6 was measured with a mouse IL-6 ELISA kit. Data (triplicate/group) 
represented as mean ± SEM,  *p < 0.05, **p < 0.01, *** p < 0.001.  All 
experiments done by Min Wang, Ph.D. 
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siRNA resulted in moderate suppression of TLR-2. However, the TLR-2 silencing 
dramatically down-regulated IL-6 mRNA expression, and production of IL-6 
protein in LCMV-ARM-infected cells. As expected, the effect of TLR-2 silencing 
on IL-6 in LCMV-WE-infected cells was minimal if any (Fig. 14). 
Co-staining experiments revealed an LCMV strain-specific pattern of 
interactions between viral antigen and endosomal markers.  TLRs sense the 
foreign invasion of microbes/viruses by recognizing their structural components 
and activate intracellular signaling pathways [219]. The TLR family includes 
receptors residing both on the cell surface, and in intracellular compartments. 
Early and late endosomes have unique TLR profile, and signaling properties 
[220, 221]. After internalization, virions are sorted into endocytic vesicles and 
delivered to endosomal/lysosomal compartments via the endocytic, and/or 
micropinocytosis pathways. LCMV and LASV enter cells through an unusual 
clathrin-, caveolin-, and dynamin-independent endocytic pathway [34, 35, 43, 44, 
190, 218].  To assess the interaction between virus-loaded vesicles, and 
trafficking through the intracellular TLR-containing compartments, mock- and 
LCMV-infected cells were stained with monoclonal against the conserved LCMV 
NP epitope, and with markers of early and late endosomes. Intracellular co-
localization of LCMV antigen and endosomal markers was visualized using 
immunofluorescence assay and confocal microscopy. 
 In the case of early endosomes, strong evidence of co-staining between 
the virus (NP antigen, green), early endosome antigen 1 (EEA1, red) and TLR-2 




Figure 15. LCMV-ARM has strong co-localization patterns of LCMV NP with 
EEA-1 and TLR-2 markers. 
RAW cells were infected with LCMV at MOI 2 PFU/cell and incubated for 30 min. 
Mock- and LCMV-infected cells were fixed, permeabilized and co-stained with 
monoclonal M104 (Abcam) against conservative NP epitope (green), EEA1 
(monoclonal F.43.1,Thermo scientific, red), and TLR2 (monoclonal CD282, 
eBioscience, light blue). Upper panels, LCMV-ARM-infected cells, right panel 
indicate a cell co-stained with all three antibodies. Extensive white area of co-
localized antigens indicated by arrow. Middle panels, LCMV-WE-infected cells, 
right panel, arrow indicates distinct staining pattern for individual antigens, no co-
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were seen as extensive white areas in the cytoplasm (Fig. 15). In contrast, all 
three colored markers had distinct staining patterns in LCMV-WE-infected cells 
with no evidence of co-staining. The small molecular weight G-protein, RAB-7, 
regulates late endocytic trafficking. Co-staining of LCMV-infected cells with anti-
NP and RAB-7 antibodies provided evidence of co-localization of target antigens 
in cells infected with both strains of LCMV, ARM and WE. Nevertheless, the co-
staining patterns were different between the two strains of virus, with evidence of 
more extensive bright-yellow areas of co-localized signals in LCMV-ARM-
infected cells (about 80%) in comparison with WE-infected cells (about 50%; 
p<0.05) (Fig.16).  
 Fusion of LASV and LCMV glycoproteins with the cell membrane is 
triggered at very low pH (3.0-4.5) suggesting that these viruses can fuse not only 
in late endosomes, but also in the lysosomal compartment [218]. A unique 
feature of LASV infection is the usage of the second receptor, lysosome-
associated membrane protein-1 (LAMP-1, CD107), to trigger low-pH- and GPC-
mediated fusion with the late endosome membrane [28, 29]. Using co-staining 
with anti-LAMP1 antibody, we have found colocalization between LCMV NP and 
LAMP-1 and; in line with previous observations, this assessment was LCMV-
strain specific (Fig. 17). Co-localization of both signals, LCMV NP antigen (green) 
and LAMP-1 (red), was clearly seen as strong yellow spots in about 80% of 
LCMV-ARM-infected cells (Fig. 17, upper right panel). While small yellow areas 
can be found in about 50% of LCMV-WE-infected cells as well, the co-staining 







Figure 16. LCMV-ARM shows more co-localization with RAB-7 marker, 
compared to LCMV-WE. 
Cells were infected with LCMV as described in legend to Fig. 11, incubated for 2 
hrs, and co-stained with M104 and RAB-7 antibodies. Upper panels, ARM-
infected cells, white arrows indicate bright yellow co-localized spots. Low 
panels, WE-infected cells, white arrows indicate diffuse light-yellow areas of co-
localization. See also Fig. 14. The analysis was performed as recently described 
for LCMV infected cells using ZEN software [214] with slight modifications. Up-to 
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eight LCMV NP-positive (green cells) cells were marked and compared pixel by 
pixel with intensity signals from each channel. Background for green and red 
channels was determined based on mock-infected cells staining. Total (green-
and red-positive) signals were divided by the sum of green positive pixels and 
expressed as co-localization efficiency, (%). The calculation was repeated for 







Figure 17. LCMV-ARM has a stronger co-staining pattern with LAMP-1 than 
LCMV-WE. 
Cells were infected and treated as indicated in legend to Fig. 12. Upper panels, 
ARM-infected cells. Lower panels, WE-infected cells. Co-staining areas are 
indicated by white arrows. See also Fig.14. The analysis was performed as 
recently described for LCMV infected cells using ZEN software  with slight 
modifications [214]. Up-to eight LCMV NP-positive (green cells) cells were 
marked and compared pixel by pixel with intensity signals from each channel. 
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Background for green and red channels was determined based on mock-infected 
cells staining. Total (green-and red-positive) signals were divided by the sum of 
green positive pixels and expressed as co-localization efficiency, (%). The 





Interaction with IRAK-1, mediator of TLR-induced signaling, is different in 
LCMV-ARM- versus LCMV-WE-infected cells.  TLR signaling is dependent on 
the recruitment of several key adaptor molecules. Upon ligand recognition, 
MyD88 (and/or Mal) recruits and activates IL-1-associated kinases (IRAK), such 
as IRAK-1, triggering a down-stream activation cascade leading to NF-kB 
translocation and transcription initiation  [222].  Notably, in cells transfected with 
an NF-κB–luciferase reporter, infection with LCMV-ARM resulted in the induction 
of NF-κB, but cells infected with LCMV-WE and immunosuppressive LCMV 
Clone 13 did not [167].  
In the next experiments, co-staining with anti-IRAK-1 antibody was 
performed in LCMV-infected murine macrophages.  As seen in Fig. 18 and Fig. 
19, little evidence of interaction between LCMV NP and IRAK-1 was found in 
LCMV-ARM-infected cells, with only 15% of the cells co-staining for LCMV NP 
and IRAK-1. In contrast, co-localized signals, identified as extensive yellow 
areas, reached about 87% in LCMV-WE-infected cells.  
In response to stimulation, IRAK-1 is subjected to ubiquitination and 
degradation, and IRAK-1 protein level remained suppressed up to 8h after 
stimulation [223]. To track LCMV strain-specific differences in IRAK-1 expression 
in infected cells, Western blot analysis was performed to detect IRAK-1 in 
infected cells (Fig. 19). While there was no difference between expressions of 
IRAK-1 at 24h after infection in LCMV-ARM and WE-infected cells, the IRAK-1 
expression levels were higher at later time points in LCMV-WE-infected cells in 






Figure 178. LCMV-WE has significant co-staining patterns with IRAK-1 
compared to LCMV-ARM. 
Cells were infected with LCMV strains and incubated for 1 hr. Upper panels, 
ARM-infected cells. Low panels, WE-infected cells. Extensive yellow areas of 
co-localized staining in WE-infected cells are shown by arrows. The analysis was 
performed as recently described for LCMV infected cells using ZEN software with 
slight modifications. Up-to eight LCMV NP-positive (green cells) cells were 
marked and compared pixel by pixel with intensity signals from each channel 
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[214]. Background for green and red channels was determined based on mock-
infected cells staining. Total (green-and red-positive) signals were divided by the 
sum of green positive pixels and expressed as co-localization efficiency, (%). The 






Figure 19. Expression of IRAK-1 in LCMV-infected cells. 
RAW267.7 cells were grown in T25 flasks and infected with LCMV viruses an 
MOI 0.1. At different time post infection, protein extracts were prepared and 
subjected to SDS-PAGE analysis as previously described [224]. In brief, protein 
samples were combined with 4X Laemmli sample buffer and loaded onto SDS-
polyacrylamide gels of 10% and 15% (w/v) acrylamide followed by 
electrophoresis and Western blotting onto PVDF membranes. Primary antibodies 
against IRAK-1 (D51G7, Cell Signaling) and GAPDH (sc-25778, Santa Cruz 
Biotechnology) were used at dilutions 1:1000 and 1:2000, respectively. Bands 



























* p<0.05; **p<0.01 in comparison with mock-infected cells
24h             48h              72h
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ECL kit (Pierce, Rockford, IL) and Hyperfilm (GE Healthcare, Piscataway, NJ). A. 
IRAK-1 was identified as a 80 kDa band.  B. Densitometric analysis was 
performed using UN-SCAN-IT gel (Silk Scientific Inc., Orem, UT) software. All 




Probing LCMV-ARM versus LCMV-WE infection with inhibitor drugs.  
Antivirals with known mechanisms of action are a useful tool to study virus-cell 
interaction and cell factors involvement in virus replication. In this study, 
representatives of three groups of drugs targeting host factors at the cell surface, 
microtubules, and cell membrane fusion in late endosomes, were used to 
validate results presented in the previous sub-sections.  
It was documented that entry of LCMV (Clone 13) was dependent upon 
membrane cholesterol [36]. To address LCMV-strain specific sensitivity to 
cholesterol depletion, Vero cells were initially used to reproduce previously 
published results [35]. The cells were pretreated with 5mM of Mβ-CD, infected 
with LCMV at an MOI of 0.3 PFU/cell, and incubated with or without drug during 
24h after infection, as described in Materials and Methods. As expected, 
replication of both strains of LCMV was affected by depletion of cholesterol on 
the cell surface (Fig. 20 A). However, when the LCMV infectious yields were 
normalized to untreated cells and compared to each other, LCMV-WE infection 
was more sensitive to the cholesterol depletion (at least 2-fold differences, Fig. 
20 C), to Mβ-CD in comparison with LCMV-ARM infection. The LCMV-strain 
specific sensitivity to cholesterol depletion was consistently observed Caco-2 
cells, independent of polarization status of these cells (Fig. 21 and Fig. 22).  
A previously published study documented that disruption of microtubules 
with nocodazole inhibited replication of LCMV-ARM [35]. In line with these 





Figure 20. Depletion of membrane cholesterol and microtubules inhibits 
LCMV-Armstrong and LCMV-WE replication in VeroE6 cells. 
Vero E6 were treated for 1 hour prior to infection with 5mM Mβ-CD (A and C) or 
10μM nocodazole (B and D), then infected with LCMV as described in Materials 
and Methods. Supernatants were collected 24 hrs after infection and virus 
production was determined by plaque assay (A and B).  Values are shown as the 
mean of 3 biological replicates with the error bar representing the standard 
deviation.  Percent replication after inhibition was normalized to untreated 
PFU/mL (C and D).  Standard T-test was used to analyze differences in titer and 
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Figure 21. Depletion of membrane cholesterol and microtubules inhibits 
LCMV-Armstrong and LCMV-WE replication in polarized Caco-2 cells. 
Caco-2 cells were seeded in 12-well plates and allowed to polarize for 3 weeks. 
Cells were treated for 1 hour prior to infection with 5mM Mβ-CD (A and C) or 
10μM nocodazole (B and D), then infected with LCMV-ARM (black) or LCMV-WE 
(grey) at a multiplicity of infection (MOI) of 0.3 PFU/cell for 1 hour on ice.  After 
infection, maintenance media was added to cells in the absence (solid) or 
presence (striped) of 5mM Mβ-CD (A) or 10μM nocodazole (C).  Supernatants 
were collected 24hours after infection and virus production was determined via 
standard plaque assay (A and C).  Values are shown as the mean of 3 biological 
replicates with the error bar representing the standard deviation.  Percent 
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replication after inhibition was normalized to untreated PFU/mL (B and D).  







Figure 182. LCMV-ARM and LCMV-WE replication is inhibited by depletion 
of membrane cholesterol, but not by microtubule disruption in non-
polarized Caco-2 cells. 
Caco-2 cells were seeded in 12-well plates. Cells were treated for 1 hour prior to 
infection with 5mM Mβ-CD (A and B) or 10μM nocodazole (C and D), then 
infected with LCMV-ARM (black) or LCMV-WE (grey) at a multiplicity of infection 
(MOI) of 0.3 PFU/cell for 1 hour on ice.  After infection, maintenance media was 
added to cells in the absence (solid) or presence (striped) of 5mM Mβ-CD (A) or 
10μM nocodazole (B).  Supernatants were collected 24hours after infection and 
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are shown as the mean of 3 biological replicates with the error bar representing 
the standard deviation.  Percent replication after inhibition was normalized to 
untreated PFU/mL (B and D).  Standard T-test was used to analyze differences 




to the drug (Fig. 20 B and D). Treatment of infected Caco-2 cells with nocodazole 
generated controversial results. In polarized cells, replication of both strains of 
LCMV was sensitive to disruption of microtubules, with LCMV-WE infection being 
more sensitive to the treatment (Fig. 21 B and D). Surprisingly, LCMV infection in 
non-polarized Caco-2 cells was not sensitive to nocodazole treatment (Fig. 22 B 
and D).   The fusion of arenavirus proteins with cell-derived membranes is the 
last step of intracellular trafficking of the virus-containing vesicles.  The low pH-
mediated fusion occurs in late endosomes/lysosomes and can be blocked by 
drugs raising pH in this sub-cellular compartment [225]. To assess LCMV strain-
specific sensitivity to inhibitors blocking fusion with cell membrane, an 
established protocol was used to treat Vero cells with bafilomycin A1 to prevent 
acidification of the late endosomes [218].  
As expected, bafilomycin treatment inhibited replication of both strains of 
LCMV in a dose-dependent manner as assessed by plaque assay and 
quantitation of viral RNA load by PCR (Fig. 24). When compared with mock-
treated cells, the differences ranging from 1-2 and 2-3 logs PFU/ml were 
observed in LCMV-WE- and ARM-infected cells, respectively (Fig. 23 A). When 
normalized to viral input, a significant difference of about 8% was observed 
between LCMV-ARM- and –WE-infected cells treated with 100 nM of bafilomycin 
(Fig. 24).  Similarly, when viral RNA was measured and normalized to mock-
treated cells, a 2-fold difference was observed between LCMV-ARM- and –WE-
infected cells, confirming higher sensitivity of LCMV-ARM infection to pH 




Figure 23. LCMV strain-specific replication sensitivity to pH increases in 
late endosomes. 
 VeroE6 cells were treated with bafilomycin A1 and infected with LCMV as 
described in Materials and Methods. Supernatants and cells were collected 24 
hrs after infection and virus production was determined via standard plaque 
assay (A) and viral mRNA was determined using qRT-PCR and normalized to 
untreated cells (B).  Standard T-test was used to analyze differences in titer and 
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Figure 194. Blocking of late endosome acidification results in a decrease in 
the percentage of viral infection in both LCMV-ARM and LCMV-WE in a 
strain-specific manner. 
VeroE6 cells were seeded in 12-well plates. Cells were treated for 1 hour prior to 
infection with varying concentrations of bafilomycin.  Cells were then then 
infected with LCMV-ARM (black) or LCMV-WE (grey) at a multiplicity of infection 
(MOI) of 1.0 PFU/cell for 1 hour on ice.  After infection, maintenance media was 
added to cells in the absence (0mM) or presence (50-200nM) of bafilomycin.  
Supernatants were collected 24 hours after infection and virus production was 
determined via standard plaque assay.  Percent infection was determined 
dividing PFU/mL by 0mM PFU values.  Data are shown as the mean of 3 
biological replicates with the error bar representing the standard deviation.  
Percent replication after inhibition was normalized to untreated PFU/mL (B and 
D).  Standard T-test was used to analyze differences in titer and percentages. * 
p≤0.05 
Vero E6 cells Treated with Bafilomycin






































 With a high genetic and biological diversity among LCMV strains, the 
behavior of WE and ARM strains of LCMV resembles phenotypic features of 
LASV and MOPV in animal models. Indeed, similar to LASV, LCMV-WE induces 
fatal disease in guinea pigs and fatal LF-like hepatitis in Rhesus macaques [194, 
195]. In both animal models, reassortant analysis revealed that the L RNA 
segment of LASV and LCMV-WE is the major genetic factor responsible for fatal 
outcome [204, 205]. Similarly, in LCMV-induced hepatitis in mice, the L 
polymerase of WE strain was primarily responsible for liver pathogenicity, with 
minimal contribution of the GPC gene [226]. Notably, a single-point K1079Q 
mutation in the L polymerase of LCMV-ARM was necessary and sufficient, in 
part, to transform LCMV-ARM into immunosuppressive Clone 13. The F260L 
mutation in GP1, which was associated with increased affinity to α-DG and 
targeting dendritic cells, played an accessory role in driving the duration of 
persistence and generalization of immunosuppression in mice [227].  Taken 
together, these results provide strong justification to consider LCMV-WE as a 
surrogate model of LASV, causing fatal hepatitis in NHPs [195].  
 Dendritic cells and macrophages are primary targets for LASV and LCMV-
WE. Dysregulation of myeloid cells, immunosuppressive features of LASV 
infection, and failure to induce sustainable innate and adaptive immunity, 
resulted in fatal LF outcome [206, 207]. In contrast, DCs and macrophages are 
strongly activated by MOPV, and the infection upregulates co-stimulatory 
molecules, IFN type I, and pro-inflammatory cytokines [106]. 
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 Strong activation of monocyte-macrophages seems to be a general 
feature of non-pathogenic mammalian arenaviruses [102, 106, 158-162]. We 
have previously demonstrated that MOPV and LCMV-ARM induced pro-
inflammatory cytokines, and this induction required virus replication and was 
dependent on TLR2/CD14/Mal/NF-κB signaling [167].  In addition to LCMV-ARM 
and MOPV, TCRV (but not pathogenic JUNV) induced cytokines release from 
macrophages as well [158]. With these similarities, TLR2/Mal/MyD88-dependent 
signaling has some differences between the OW and NW mammalian 
arenaviruses. In the case of Candid 1 (attenuated JUNV vaccine), engagement 
of TLR2/6 heterodimers on cell surface by viral glycoprotein was sufficient to 
trigger cytokine response via RIG-I/MDA5, NF-κB, and Erk1/2 pathways and did 
not require internalization and viral replication. 
 In this study, we provide additional evidence of TLR-2 involvement in the 
induction of pro-inflammatory cytokines by LCMV-ARM (not LCMV-WE), since 
TLR-2 silencing resulted in abrogation of the response to LCMV-ARM. 
Accumulated evidence demonstrates a role for TLR-2 in sensing mammalian 
arenaviruses with different pathogenic potential [159-161, 167, 228, 229]. Viral 
glycoprotein are recognized as a TLR-2 ligand for JUNV (wild type and vaccine 
strain) [229], however, a TLR-2 ligand has not been identified for the OW 
arenaviruses. Viral glycoproteins of the OW mammalian arenaviruses can be 
considered as TLR-2 ligands similar to JUNV. However, in contrast to JUNV, 
TLR2/CD14/Mal-dependent signaling induced by MOPV and LCMV-ARM 
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required virus replication [167], indicating a more complex nature of virus-
induced innate responses.    
 In addition to TLR-2, LCMV and LASV induce TLR-7 and TLR-9 
responses and activate RIG-I [230]. These major machineries initiate intracellular 
signaling via common cytoplasmic adapters (e,g., MyD88/Mal, TRIF, IPS-1) to 
induce IFN type I and NF-κB-dependent pro-inflammatory cytokines. It seems 
intracellular TLRs involved in arenavirus recognition have different intracellular 
localization [220, 221]; TLR-2 has been mostly associated with early endosomes 
(Fig. 2), while  TLR-7 and TLR-9 have been sitting predominantly in late 
endosomal compartment since treatment with bafilomycin A1 and chloroquine 
inhibits the activation of nucleic acid sensing TLRs [221].   
Pathogenic viruses have developed tricky mechanisms to subvert 
endocytic and pathogen-sensing functions of DCs and macrophages to avoid 
effective recognition and immune control [231].  As seen in Fig. 15-17, ARM and 
WE strains of LCMV had different patterns of intracellular trafficking and 
interaction with endosomal compartments. Non-pathogenic (for NHPs) LCMV-
ARM was tightly interacted with early and late endosomes, as it was revealed by 
co-staining with EEA-1, RAB-7 and LAMP-1 markers.  Alternatively, LCMV-WE, 
causing fatal LF-like hepatitis in NHPs, effectively avoid early endosome 
recognition. Consistent with this, penetration kinetics study documented that 
LCMV-WE reached late endosomes by bypassing RBA5/EEA1-positive 
compartment [44]. Notably, in late endosomal/lysosomes, LCMV-WE infection 
demonstrated less extensive interaction with RAB-7 and LAMP-1 markers. 
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 After interaction with cell surface receptors, LASV switches to a second 
receptor, LAMP-1, to fuse with cell membrane in late endosomes/lysosomes [28].  
While recent studies provided evidence that LAMP-1 is not absolutely required 
for LASV infection [50], LAMP-1 increases efficiency of infection by promoting 
fusion in less acidic endosomal environment. Interestingly, LAMP-1 binding site 
interaction with LASV GP1 has not been shown to be shared by other OW 
arenaviruses, and was not found in MOPV and LCMV [49]. It seems the LAMP-1 
positive co-staining pattern observed in LCMV-infected cells (Fig. 4) does not 
relate to LCMV GP1 and is probably linked to glycoprotein responsible for fusion, 
GP2. 
 To elicit MyD88/Mal-dependent pro-inflammatory responses, IRAK-4 is 
recruited to phosphorylate IRAK-1 and IRAK-2, to further activate down-stream 
cascade via the E3 ubiquitin ligase TRAF-6 and TAK-1 phosphorylation of  IKKβ,  
resulting in IκB degradation and release of NF-κB [220]. Interestingly enough, 
LCMV-WE infection of murine macrophages resulted in strong co-localization of 
viral NP with IRAK-1 (Fig. 5). Taking into consideration suppression of NF-κB in 
LCMV-WE-infected cells [167], this co-staining pattern seems to contribute to the 
immunosuppressive phenotype of LCMV-WE, but preventing transcription of NF-
κB factors. 
 Epithelial cells of the gastrointestinal tract and upper-respiratory system 
are major gates of entry for LASV and LCMV. An epidemiological study in LASV 
endemic areas identified the hunting of peridomestic rodents and consumption of 
LASV-contaminated food, as risk factors for rodent-to-human transmission [137]. 
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Similar to LASV, LCMV was resistant to low pH after oral (lavage) application. 
Notably, experiments in mice [169, 170, 232], and NHPs [155, 156, 182], suggest 
that crossing the gastric/intestinal mucosa resulted in virus attenuation and 
protection of animals against subsequent fatal challenge. Experiments in NHPs 
revealed clear differences in pathogenic potential between LCMV-ARM, causing 
deeply attenuated asymptomatic infection, and LCMV-WE, inducing LF-like fatal 
disease in all animals after systemic application. Notably, while in some animals, 
oral inoculation of LCMV-WE resulted in viremic manifested disease, animals 
recovered and became protected against fatal intravenous challenge [182]. 
The possible LCMV strain-specific interaction with gastrointestinal 
epithelia was tested in polarized Caco-2 cells, and both strains of LCMV, 
demonstrated similar attachment/binding profile in these cells [208]. In this study, 
Caco-2 cells were used to test well-characterized drugs affecting membrane 
cholesterol and disrupting microtubular transport. Previous studies documented 
that attachment of OW mammalian arenaviruses to cellular receptors occurs 
independently on cholesterol, while cholesterol depletion affected internalization 
and reduced replication indicating that efficient virus infection required membrane 
cholesterol [35, 138]. In line with these results, treatment of Vero and Caco-2 
cells (non-polarized and polarized) consistently demonstrated high sensitivity of 
LCMV-WE infection (vs. LCMV-ARM) to cholesterol depletion (Fig. 20, 21, and 
22, A and C).  
While the actin cytoskeleton is not required for LCMV pseudotypes and 
LCMV-ARM replication, disruption of microtubules with nocodazole affected 
105 
 
replication of these viruses in CV1 cells [35]. Consistently, the drug had similar 
inhibitory effect on replication of both strains of LCMV in Vero cells. Interestingly 
enough, polarization status of Caco-2 also had effect on strain-specific sensitivity 
of LCMV to nocodazole. In polarized cells, LCMV-WE infection was more 
sensitive to disruption of microtubules (Fig. 21 B and D). In contrast, replication 
of both strains of LCMV in non-polarized cells was not affected by nocodazole 
(Fig. 22, B and D). It suggests that polarization itself promotes contribution of 
microtubules to virus replication and results in LCMV strain-specific sensitivity to 
the drug (Fig. 22 C and D).  
 The final step of the endocytic pathway is pH-dependent fusion with cell 
membranes at late endosomes/lysosomes, and the release of viral RNA to 
initiate productive infection. Using lysosomotropic agents (NH4Cl, chloroquine, 
monensin) we [225], and others [213] documented that LASV infection was more 
resistant to pH increase in comparison to non-pathogenic MOPV. This is in line 
with findings that demonstrated a very low pH requirement for LASV fusion [218].  
Similar to lysosomotropic compounds, bafilomycin A1, an inhibitor of proton 
pumps, prevents acidification of late endosomes. Consistently, bafilomycin A1 
also inhibited LASV and LASV pseudoparticles entry in dose-dependent manner 
[218]. Bafilomycin treatment of LCMV-infected cells resulted in inhibition of LCMV 
replication as well (Fig. 7, S5). Importantly, we have found that LCMV-WE 
infection was more resistant to bafilomycin A1 than LCMV-ARM infection, in good 
collaboration with LASV vs. MOPV sensitivity to lysosomotropic compounds [213, 
225]. Different sensitivity of pathogenic vs. non-pathogenic OW arenaviruses to 
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pH increase in late endosomes/lysosomes can affect viral RNA release kinetics. 
Additionally, change in pH can affect activation pattern of nucleic acid sensing 
TLR-7, TLR-9 and RIG-I driving expression of IFNs and pro-inflammatory 
cytokines. These factors are crucially involved in activation of antigen presenting 
cells and T cells stimulation resulting in efficient adaptive responses to control 
viral infection in case on infection with non-pathogenic viruses. In contrast, the 
immunosuppressive phenotype of LASV and LCMV-WE in addition with 
intracellular trafficking avoiding exposure with TLRs and delayed TLR-7, TLR-9 
and RIG-I activation contributed to adaptive immune failure.  Strong interaction 
between LASV NP and IRAK-1 in LCMV-infected cells is consistent with ability of 
this infection down-regulate NF-κB activity in infected cells [167]. 
CONCLUSIONS 
 
In summary, in this study we demonstrated clear differences in terms of 
intracellular trafficking and sensitivity to pharmacological drugs between two 
strains of LCMV with different pathogenic potential for NHPs, WE and ARM. 
Consistent with previous results, LCMV-ARM co-staining pattern and interaction 
with endosomal compartments hosting TLRs, promotes induction of strong innate 
responses via TLR2/CD14/Mal-dependent signaling pathways. In addition, higher 
sensitivity of LCMV-ARM infection to bafilomycin A1 treatment suggests efficient 
release of viral RNA to activate nucleic acid sensing TLRs and RIG-I, contributing 










The overall objective of this research was to identify an intestinal epithelial 
cell culture model that could further lead us to understand how OW arenaviruses 
were interacting at the sight of intragastric infection, as well as investigate 
potential factors that drive pathogenic differences between viruses sharing 
similar genetic phenotypes. In order to study these differences, we utilized a well-
developed intestinal epithelial model, polarized Caco-2 cells, to identify 
characteristics of infection with different OW arenaviruses.  In addition, we used 
chemical inhibitors to identify differences in intracellular pathways of these 
closely related viruses.   
In some villages in LASV endemic regions in West Africa up to 45% of the 
populations is seropositive for the virus, allowing for clearance of the disease 
without manifestation upon reinfection [81].  However, what defines why some 
individuals are seropositive and can protect themselves from disease onset, 
while others show clinical manifestation of LF, has yet to be defined.  Our first 
goal was to develop and characterize a cell culture system as an in vitro model to 
investigate the interaction of OW mammalian arenaviruses at the sight of 
intragastric inoculation.  
Caco-2 cell polarization results in development of tight junction proteins, 
monolayers of connected cells, and organizational patterns that differ from non-
polarized cell types [173].  The first step was characterizing how different OW 
arenaviruses interact at the site of intragastric inoculation.  Due to the difference 
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in phenotypes of polarized and non-polarized cells, we analyzed this in the 
context of viral replication in Caco-2 cells.  We found that the polarity of this cell 
line did not impact the replication kinetics of LCMV, MOPV, or ML-29.   
In vivo experimentation with LCMV in non-human primates showed a 
significant difference between intravenous and intragastric routes of inoculation 
[155, 182].  Additionally, access to cellular receptors differs with exposure to 
different surfaces of the epithelia [138, 139]. Furthermore, in vitro studies have 
shown that entry and release from polarized epithelia is viral specific, and 
location of viral receptor was indication for direction of viral entry [138, 139].     
Here, we investigated the patterns of entry and release when these viruses were 
exposed to the apical or the basolateral surface of polarized Caco-2 cells.  
Interestingly, we discovered that LCMV-Armstrong and WE, despite having 
different pathogenic potential in Non-human primates (NHPs), entered and 
released via a similar pattern in Caco-2 cells.  When LCMV-ARM and LCMV-WE 
were exposed to the apical side of the intestinal epithelia, mimicking an 
intragastric infection, we observed high replication and release from the apical 
surface of these cells, and almost equal release from the basolateral surface.  
Additionally, when exposed to the basolateral surface of polarized Caco-2 cells, 
LCMV and MOPV entered apically and released primarily from the apical side, 
with very little release observed from the basolateral side.  Furthermore, we 
found that ML-29, a LASV surrogate mimicking LASV interaction with susceptible 
cells, had a different pattern of replication from its parent MOPV strain. When 
exposed to the apical side of these polarized cells, ML-29 released primarily from 
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the apical surface with little to no egress on the basolateral side.  Interestingly, 
when exposed basolaterally, ML-29 showed a delay in viral replication, and did 
not release infectious progeny until day 5 post infection. The release was 
observed primarily on the apical surface.  Successful entry and release of viral 
progeny was seen with LCMV and MOPV on both the apical and basolateral 
side, and only on the apical surface of these cells, indicating that alternative 
cellular receptors may be associated with entry into polarized intestinal epithelia. 
Therefore, further investigation into the usage of alternative receptors Axl, DC-
SIGN, and TYRO-3, should be completed.  Our immunofluorescence staining 
showed location of α-DG to be primarily located on the basolateral side; but fixed 
cells represent only a snapshot of the cellular environment, thus the 
characterization of cellular receptors in real-time may be a useful addition toward 
fully understanding the interaction of these viral-receptor interactions    
To further characterize attachment efficiency of the viruses to the apical 
and basolateral sides of Caco-2 cells, attachment efficacy was measured by 
qRT/PCR.  Interestingly, a lower attachment of ML-29 to the basolateral surface 
of these cells (the surface of the polarized epithelia in which ML-29 failed to 
produce progeny), was observed, as opposed to the apical side of cells.  
Comparatively, LCMV and MOPV attached similarly, with almost equal ratios to 
the apical and basolateral surfaces of these cells.  The MOPV backbone used in 
ML-29, is genetically very similar to that of LASV, compared to other psudotype 
particles with VSV- or retro-based particles.  Additionally, ML-29 has GP1, the 
attachment protein, that is identical to LASV, making ML-29 the best model to 
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mimic LASV-cell interaction.  However, differences in intracellular trafficking 
between ML-29 and LASV has yet to be shown.  This is most likely due to the 
K272E substitution, and the mutation located between two peptides at the N-
terminal of the GP2 [77, 85, 184, 185, 205]. This mutation may impact the fusion, 
and/or post fusion events of ML-29, resulting in different patterns of replication in 
polarized Caco-2 cells infected with LASV. Interestingly, GP2 mutation in the 
JUNV vaccine strain Candid #1 appears to be involved in the destabilization of 
the metastable GP conformation, contributing to attenuation [233]. The Candid 
#1 GP2 was significantly less affected by NH4Cl (to block the endosomal 
acidification) than wild type GP2 [233]. The key role of Candid #1 GP2 mutant 
was recently confirmed by reverse genetics [234] and this mutation was 
proposed to be a molecular signature of JUNV attenuation [233].  Additionally, 
the dynamic interactions of GP1 with cellular receptors, should be investigated.  
Previous research has determined the crystal structure of LCMV-ARM and 
LCMV-WE, finding that there is no significant differences between the structure 
of these two GP1 proteins [209].  However, other studies suggest that LCMV-
ARM does not maintain as strong an affinity to α-DG, as LCMV-WE [25].     
 In the in vitro Caco-2 model of intestinal epithelia, the strains of LCMV, 
Armstrong and WE, were compared to mimic intravenous versus intragastric 
inoculation of these virsuses.  These two strains of virus, though genetically very 
similar, have different pathogenic potentials in animal models, including non-
human primates.  While LCMV-ARM-infected non-human primates develop sub-
clinical infection, LCMV-WE-infected monkeys develop severe LF-like fatal 
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hepatitis. The LCMV-WE infection results in elevated AST and ALT levels, 
severe liver pathology, and high viremia [153, 155].  However, when 
intragastrically infected with these two strains of LCMV, animals responded in a 
dose dependent manner. With a low dose of LCMV-WE, most animals did not 
show signs of disease manifestation compared to intravenous inoculation [155].  
However, animals that were infected intragastrically with a very high dose of WE, 
resulted in manifested disease or died [155, 182].  Nevertheless, when 
challenged with lethal levels of WE intravenously, animals were protected against 
fatal challenge [182].  To further characterize the differences between these two 
strains of LCMV, we utilized Caco-2 cells to identify how these viruses differed in 
polarized intestinal epithelia.  Interestingly, these strains showed similar 
phenotypes in their replication in our polarized Caco-2 model.  Additionally, we 
found that viral attachment to the apical and basolateral surfaces of the Caco-2 
cells was very similar between the two viruses, although LCMV-ARM did seem to 
prefer the apical surface.  However, the question still lies as to why these two 
strains cause such different phenotypes in NHPs.  Since the attachment 
efficiency to polarized cells, and the phenotype of replication was not different 
between the two viruses, then investigation into the intracellular trafficking 
needed to be completed.   
In order investigate these trafficking patterns, we utilized several chemical 
inhibitors, as well as confocal microscopy staining, to identify potential 
differences between LCMV-ARM and WE during intracellular trafficking in 
epithelial and macrophage cell lines.  Macrophages are among the first cells to 
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come in contact with the virus after crossing of the epithelial barrier.  However, it 
has been shown that LASV prevents activation of macrophages and dendritic 
cells (DCs) in culture [106, 107], signified by lack of immune mediators and 
costimulatory molecules such as TNF-α, IL-1β, IL-6, IL-19, CD 40, CD 54, CD 80, 
and CD86 [106].  Additionally, LCMV-WE and LASV have been shown to down-
regulate innate pro-inflammatory responses in vitro and in vivo, and are able to 
inhibit Toll-like receptor 2 (TLR2)/MyD88 adaptor-like (Mal)-dependent cytokines, 
as compared to LCMV-ARM and MOPV [90, 102, 153, 156, 167]. Here, when 
RAW264.7 cells were infected, LCMV-ARM induced IL-6, compared to no 
response in LCMV-WE-infected cells. Additionally, when TLR-2 was silenced in 
RAW264.7 cells, LCMV-ARM-infected macrophages were unable to produce IL-
6, much like that of WE-infected macrophages.  Furthermore, LCMV-ARM co-
localization with TLR-2 and EEA1, as opposed to LCMV-WE, indicating that 
LCMV-WE does not utilize early endosomes during infection of macrophages.  
Furthermore, we investigated the presence of LCMV-ARM and WE colocalizing 
with late endosome/lysosomal markers as well.  Interestingly, we found 
colocalization patterns in both LCMV-ARM- and LCMV-WE-infected cells, 
although a stronger colocalization pattern was seen for ARM infected cells, 
signifying that both LCMV-ARM and WE utilize the late endosome during entry.              
Furthermore, we identified that LCMV-WE was more dependent on 
membrane cholesterol utilization in VeroE6 and polarized/non-polarized Caco-2 
cells, as compared to LCMV-ARM.  This signifies that there may be potential 
differences between how these two viruses utilize and interact with their 
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receptors and cell membranes during viral attachment and entry.  However, 
when microtubules were disrupted through the use of Nocodazole, LCMV-ARM 
and WE were both impacted by the drug, however, the difference of inhibition 
between the two viruses was not significant, indicating that these two viruses 
utilize microtubules in a similar manner.   
The most interesting finding during these experiments was the effect of 
bafilomycin treatment.  Bafilomycin, an inhibitor of late endosome acidification, 
was present prior to, during, and after infection, in a number of concentrations.  
Interestingly, we saw significant differences between how LCMV-ARM and 
LCMV-WE were impacted by late endosome acidification.  LCMV-Armstrong was 
more highly sensitive to blocking the acidification of the late endosome, than 
LCMV-WE. A similar observation was observed between LASV and MOPV [225].  
Non-pathogenic MOPV was very sensitive to ammonium chloride treatments as 
compared to LASV, signifying the ability of LASV to release viral RNA faster than 
that of MOPV [225]. These results indicate that LCMV-WE is capable of allowing 
the virus to fuse and continue with replication faster than that of LCMV-ARM.  
This ability to fuse during more basic environments signifies that LCMV-WE may 
not need to proceed to the late endosome or lysosome before releasing viral 
RNA into the cytoplasm, resulting in a potential to release infectious progeny 
sooner, and manipulate or bypass innate immune regulation, as seen with our 






ML-29 is a desirable candidate as a LASV vaccine.  Several studies have 
been used to identify the protective capacity of this reassortant virus on LASV 
challenges [84, 85, 87, 91].  ML-29 is capable of protecting against several 
strains of LASV, and shows potential to have some cross-protective tendencies 
for LCMV-WE [87].  A large percentage of the population in LASV-endemic 
regions are seropositive for the virus and do not show clinical signs and 
symptoms of the disease.  Further studies into how WT LASV enters, releases, 
and attaches to polarized Caco-2 cells would provide valuable knowledge for the 
field to better understand potential factors resulting in seropositivity and 
protection against LASV infection and disease in endemic regions.  Additionally, 
due to the results that we have observed with ML-29 in vitro, along with the in 
vivo challenge studies, it would be interesting to investigate how the route of 
vaccination influences the protective abilities of ML-29.  Intravenous and 
subcutaneous methods of vaccination have been investigated, however, 
intragastric inoculation has yet to be explored.  Additionally, intragastric routes of 
inoculation in a mouse, guinea pig, and/or a NHP model has yet to be 
investigated with LASV-infected animals.  Similar studies have been done with 
the prototypic arenavirus, LCMV, utilizing different strains to determine 
differences in pathogenicity [155, 182], however, LASV has yet to be 
investigated.  
Caco-2 cells, as an intestinal epithelial model, are useful in determining 
the cellular interactions of these mammalian arenaviruses.  However, these cells 
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to not mimic a complete model of the intestinal environment.  Although Caco-2 
cells polarize and develop into enterocyte-like cells, this model only depicts one 
aspect of the in vivo environment.  The intestinal environment is a highly 
immune-active site of the body and through our cell culture model, we are unable 
to determine the role of immune regulators such as Dendritic cells (DCs), 
macrophages, M cells, and Peyers patches.  The Caco-2 cell culture model 
mimics only the intestinal epithelia, not allowing us to investigate other key 
players that may have an impact on how these viruses are interacting with the 
intestine during intragastric infection.   We did discover, that LCMV and MOPV 
primarily release to the intestinal lumen; however, there was a slight release of 
infectious progeny to the basolateral side.  However, when tested in vivo, 
intragastric inoculation resulted in no detectible virus in any tissues collected 
from the experiments [155], bringing to question, the role of immune cells present 
at the site of inoculation. A potential experimental setup to study these 
interactions may be to utilize a co-culture model.  While Caco-2 cells are grown 
on transwell inserts, macrophages would be cultured in the bottom transwells, 
and the intestinal epithelia would be infected with different strains of LCMV.  
Moreover, investigating the infection of macrophages and determining how these 
infections may impact epithelial barrier integrity.  Furthermore, LASV has been 
known to downregulate and inhibit INF responses and prevent macrophages and 
DCs from activating.  It would be of interest to determine how LASV interacts with 
these immune regulators of the digestive system in order to further and more 
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clearly understand the seropositive-phenotype that is observed in LASV-endemic 
populations.   
 While LASV does indeed infect a large number of the population, only a 
small subset of this population results in clinical manifestations of disease, and 
an even smaller population dies annually from these infections.  However, what 
has yet to be identified is what differentiates populations that are seropositive 
with subclinical infections, from those that succumb to infection that results in 
severe illness and even death.  Western Africa is not just home to LASV; several 
other viruses including Ebola, Marburg virus, Rift Valley Fever, Crimean-Congo 
hemorrhagic fever, flaviviruses, and alphaviruses reside in this region [235].  In 
addition, influenza, cholera, and malaria have been identified as human 
pathogens in West Africa.  Recent studies investigating concurrent infection of 
malaria and dengue viral infection have been investigated, and co-infection of 
these two pathogens is higher than initially thought, and clinical symptoms are 
likely be more severe than single infection [236].  Additionally, a preliminary sero-
epidemiology study of LASV and HIV shows that there is potential for connection 
between these two viruses.  However, there has yet to be controlled 
experimentation as to how these other diseases could potentially play a role in 
LASV pathogenicity.  One potential factor that should be considered is the role of 
the intestinal and bronchial barriers during LASV infection.  For example, if a 
patient has been infected with an agent that causes intestinal barrier disruption, 
this may play a potential role in the viral entry and its ability to develop systemic 
infection.  In the case of LCMV-ARM and WE in rhesus macaques, LCMV-WE 
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induced systemic infection with fatal outcome, however when intragastrically 
infected, this virus was not capable of systemic disease, but rather a localized 
infection.  It would be of interest to investigate how this barrier system plays a 
role in keeping a localized infection in NHPs or other animal models during 
LCMV and LASV infection.  Additionally, these experiments may provide insight 
as to why such a high seroprevalence of LASV is present in Western Africa and 
why not all patients succumb to disease.   
 While in our hands, ML-29 did not have successful replication in Madin-
Darby Canine Kidney (MDCK) epithelial cells, however, previous studies have 
shown LASV’s ability to replicate sufficiently in these cells [138].  Additionally, 
bronchial epithelia have been used to study LCMV [139], however, in our Human 
bronchial epithelial (HBE) model, we had insufficient replication of LCMV-ARM 
and did not further characterize other viruses in this model.  It would be of 
interest however, to utilize a number of different polarized epithelial types to 
determine how LCMV-ARM, LCMV-WE, MOPV, and ML-29 replicate in these 
other cell types.  This would provide further support for our hypothesis that 
arenavirus replication is host, virus, and tissue specific.  By investigating how 
these viruses interact with different tissues, this may further explain the 
seropositivity seen with small populations in West African villages.  Additionally, 
these phenotypes would provide further support for ML-29 as a vaccine 
candidate.  For example, while we did not see sufficient release to the 
basolateral surface of the Caco-2 cells with ML-29, we saw release only from the 
apical surface of these cells.  In return, this may be a beneficial aspect of ML-29 
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as a vaccine candidate, providing only localized intestinal infection, resulting in 
the immune system having exposure to and time to mount sufficient and 
producing neutralizing immune responses.            
 Additionally, New World (NW) mammalian arenaviruses, though related to 
the OW group, have differences in pathogenic phenotypes, receptor usage, and 
global location.  However, these NW viruses are transmitted through their rodent 
reservoirs in the same way as their OW relatives.  It would be of interest to utilize 
the Caco-2 model developed her for OW arenaviral infection, to investigate the 
patterns of replication with NW viruses.  Due to the differences in receptor usage, 
there may be interesting findings in how these viruses replicate and utilize 
intestinal epithelia in vitro.  Furthermore, while there is a successful vaccine for 
Junin virus, Candid # 1, there has yet to be a vaccine created for Machupo, 
another highly pathogenic NW arenavirus.  By investigating these interactions 
with the intestinal epithelia, there may be interesting findings that may benefit the 
development of a new Machupo vaccine. 
 We have identified several differences in the intracellular trafficking 
between LCMV-ARM and WE.  However, we have not exhausted the viral 
replication of these two viruses.  It would be of interest to determine intracellular 
trafficking with additional inhibitors.  Manipulation of the multivesicular bodies of 
host cells during arenaviral infection has been identified as part of the arenaviral 
life cycle.  Multivesicular bodies are able to be disrupted using the PI3KI inhibitor 
wortmannin.  Additionally, it would be of interest to knockdown late endosome 
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fusion of LAMP1 and determine its effect of viral replication between ARM and 
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